This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-21-5p | AKT2 | 1.51 | 0 | -0.34 | 1.0E-5 | miRNAWalker2 validate | -0.25 | 0 | NA | |
2 | hsa-miR-330-5p | AKT2 | 0.44 | 0.00533 | -0.34 | 1.0E-5 | miRanda | -0.1 | 1.0E-5 | NA | |
3 | hsa-miR-342-3p | AKT2 | -0.32 | 0.04498 | -0.34 | 1.0E-5 | mirMAP | -0.12 | 0 | NA | |
4 | hsa-miR-106b-5p | AKT3 | 0.65 | 0 | -0.66 | 0.00047 | miRNATAP | -0.26 | 0.00148 | NA | |
5 | hsa-miR-107 | AKT3 | 0.24 | 0.01708 | -0.66 | 0.00047 | PITA; miRanda | -0.6 | 0 | NA | |
6 | hsa-miR-122-5p | AKT3 | -1.24 | 0 | -0.66 | 0.00047 | miRNAWalker2 validate; miRTarBase | -0.28 | 0 | 24244539 | miR 122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3; Here we identify AKT3 as a novel and direct target of miR-122; Restoration of miR-122 expression in HCC cell lines decreases AKT3 levels inhibits cell migration and proliferation and induces apoptosis; These anti-tumor phenotypes can be rescued by reconstitution of AKT3 expression indicating the essential role of AKT3 in miR-122 mediated HCC transformation; Our data strongly suggest that miR-122 is a tumor suppressor that targets AKT3 to regulate tumorigenesis in HCCs and a potential therapeutic candidate for liver cancer |
7 | hsa-miR-146b-5p | AKT3 | 0.42 | 0.04574 | -0.66 | 0.00047 | miRNAWalker2 validate | -0.16 | 0.00026 | NA | |
8 | hsa-miR-15a-5p | AKT3 | 0.35 | 0.00077 | -0.66 | 0.00047 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.27 | 0.00291 | NA | |
9 | hsa-miR-17-3p | AKT3 | 0.41 | 0.00422 | -0.66 | 0.00047 | miRNATAP | -0.35 | 0 | NA | |
10 | hsa-miR-17-5p | AKT3 | 0.7 | 2.0E-5 | -0.66 | 0.00047 | TargetScan; miRNATAP | -0.29 | 0 | NA | |
11 | hsa-miR-20a-5p | AKT3 | 0.85 | 0 | -0.66 | 0.00047 | miRNATAP | -0.29 | 0 | NA | |
12 | hsa-miR-32-3p | AKT3 | 0.22 | 0.20722 | -0.66 | 0.00047 | mirMAP | -0.23 | 4.0E-5 | NA | |
13 | hsa-miR-33a-3p | AKT3 | -0.68 | 1.0E-5 | -0.66 | 0.00047 | mirMAP | -0.23 | 0.0001 | NA | |
14 | hsa-miR-362-3p | AKT3 | 0.81 | 0 | -0.66 | 0.00047 | miRanda | -0.22 | 0.00083 | NA | |
15 | hsa-miR-362-5p | AKT3 | 0.72 | 2.0E-5 | -0.66 | 0.00047 | PITA; TargetScan; miRNATAP | -0.15 | 0.00734 | NA | |
16 | hsa-miR-374a-5p | AKT3 | 0.02 | 0.86978 | -0.66 | 0.00047 | mirMAP | -0.28 | 0.00294 | NA | |
17 | hsa-miR-502-3p | AKT3 | 0.66 | 0 | -0.66 | 0.00047 | miRNATAP | -0.26 | 0.0008 | NA | |
18 | hsa-miR-616-5p | AKT3 | 0.15 | 0.40284 | -0.66 | 0.00047 | mirMAP | -0.2 | 0.0001 | NA | |
19 | hsa-miR-93-5p | AKT3 | 1.4 | 0 | -0.66 | 0.00047 | miRNATAP | -0.28 | 1.0E-5 | NA | |
20 | hsa-miR-204-5p | ARRB1 | -0.54 | 0.03309 | -0.7 | 0.00013 | MirTarget | -0.16 | 0 | NA | |
21 | hsa-miR-361-5p | ARRB1 | 0.23 | 0.00962 | -0.7 | 0.00013 | MirTarget; miRanda | -0.3 | 0.00301 | NA | |
22 | hsa-miR-365a-3p | ARRB2 | 0.16 | 0.15325 | 0.02 | 0.8458 | MirTarget; miRNATAP | -0.15 | 0.00125 | NA | |
23 | hsa-miR-21-5p | ATF2 | 1.51 | 0 | -0.24 | 0.15619 | miRNAWalker2 validate | -0.18 | 0.00336 | NA | |
24 | hsa-miR-30b-5p | ATF2 | -0.54 | 2.0E-5 | -0.24 | 0.15619 | mirMAP | -0.22 | 0.00045 | NA | |
25 | hsa-miR-107 | BDNF | 0.24 | 0.01708 | 0.05 | 0.83189 | MirTarget; PITA; miRanda; miRNATAP | -0.55 | 0 | 27498977 | MicroRNA 107 inhibits tumor growth and metastasis by targeting the BDNF mediated PI3K/AKT pathway in human non small lung cancer; In addition BDNF expression was upregulated and inversely correlated with miR-107 in NSCLC tissues; Enforced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-107 on NSCLC proliferation migration and invasion; miR-107 overexpression or downregulation of BDNF was able to inhibit activation of PI3K/AKT signaling pathway; Taken together our findings present the first evidence that miR-107 could suppress NSCLC metastasis by targeting BDNF and indirectly regulating PI3K/AKT signaling pathway which might lead to a potential therapeutic strategy focusing on miR-107 and BDNF for human NSCLC |
26 | hsa-miR-148a-5p | BDNF | -0.77 | 0 | 0.05 | 0.83189 | mirMAP | -0.26 | 0.00044 | NA | |
27 | hsa-miR-192-3p | BDNF | -0.64 | 0.00027 | 0.05 | 0.83189 | MirTarget; miRNATAP | -0.32 | 0 | NA | |
28 | hsa-miR-30d-5p | BDNF | 0.72 | 0 | 0.05 | 0.83189 | miRNATAP | -0.3 | 0.00095 | NA | |
29 | hsa-miR-589-5p | BDNF | 1.19 | 0 | 0.05 | 0.83189 | miRNATAP | -0.24 | 0.00999 | NA | |
30 | hsa-miR-107 | CACNA1C | 0.24 | 0.01708 | 0.95 | 1.0E-5 | miRNATAP | -0.48 | 0 | NA | |
31 | hsa-miR-186-5p | CACNA1C | -0.06 | 0.53529 | 0.95 | 1.0E-5 | mirMAP | -0.52 | 0 | NA | |
32 | hsa-miR-192-5p | CACNA1C | -0.5 | 0.00345 | 0.95 | 1.0E-5 | mirMAP | -0.49 | 0 | NA | |
33 | hsa-miR-19b-1-5p | CACNA1C | -0.28 | 0.07831 | 0.95 | 1.0E-5 | MirTarget | -0.2 | 0.00251 | NA | |
34 | hsa-miR-26b-5p | CACNA1C | -1.11 | 0 | 0.95 | 1.0E-5 | MirTarget; miRNATAP | -0.31 | 0.00037 | NA | |
35 | hsa-miR-30e-5p | CACNA1C | -0.63 | 0 | 0.95 | 1.0E-5 | mirMAP | -0.38 | 0.00024 | NA | |
36 | hsa-miR-33a-5p | CACNA1C | -0.77 | 1.0E-5 | 0.95 | 1.0E-5 | MirTarget | -0.28 | 0 | NA | |
37 | hsa-miR-33b-5p | CACNA1C | -2.29 | 0 | 0.95 | 1.0E-5 | MirTarget | -0.18 | 2.0E-5 | NA | |
38 | hsa-miR-378a-5p | CACNA1C | -1.59 | 0 | 0.95 | 1.0E-5 | MirTarget | -0.19 | 0.00057 | NA | |
39 | hsa-miR-532-5p | CACNA1C | 1.03 | 0 | 0.95 | 1.0E-5 | PITA | -0.22 | 0.00512 | NA | |
40 | hsa-miR-618 | CACNA1C | 0.14 | 0.51715 | 0.95 | 1.0E-5 | PITA | -0.31 | 0 | NA | |
41 | hsa-miR-7-1-3p | CACNA1C | -0.57 | 2.0E-5 | 0.95 | 1.0E-5 | MirTarget | -0.35 | 1.0E-5 | NA | |
42 | hsa-miR-93-3p | CACNA1C | 0.4 | 0.00131 | 0.95 | 1.0E-5 | mirMAP | -0.35 | 4.0E-5 | NA | |
43 | hsa-let-7a-2-3p | CACNA1D | -1.19 | 0 | 0.08 | 0.77567 | MirTarget | -0.19 | 0.00174 | NA | |
44 | hsa-miR-101-3p | CACNA1D | -1.48 | 0 | 0.08 | 0.77567 | miRNATAP | -0.43 | 1.0E-5 | NA | |
45 | hsa-miR-139-5p | CACNA1D | -2.11 | 0 | 0.08 | 0.77567 | miRanda | -0.23 | 0.00032 | NA | |
46 | hsa-miR-144-3p | CACNA1D | -2.98 | 0 | 0.08 | 0.77567 | miRNATAP | -0.14 | 0.0026 | NA | |
47 | hsa-miR-148a-5p | CACNA1D | -0.77 | 0 | 0.08 | 0.77567 | MirTarget; miRNATAP | -0.49 | 0 | NA | |
48 | hsa-let-7a-2-3p | CACNA1E | -1.19 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.44 | 0 | NA | |
49 | hsa-let-7a-5p | CACNA1E | -0.33 | 0.00046 | 1.61 | 4.0E-5 | TargetScan; miRNATAP | -1.16 | 0 | NA | |
50 | hsa-let-7b-5p | CACNA1E | -0.96 | 0 | 1.61 | 4.0E-5 | miRNATAP | -0.58 | 1.0E-5 | NA | |
51 | hsa-let-7f-5p | CACNA1E | -0.23 | 0.10329 | 1.61 | 4.0E-5 | miRNATAP | -0.53 | 0.00011 | NA | |
52 | hsa-let-7g-3p | CACNA1E | -1.14 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.65 | 1.0E-5 | NA | |
53 | hsa-let-7g-5p | CACNA1E | -0.46 | 2.0E-5 | 1.61 | 4.0E-5 | miRNATAP | -0.98 | 0 | NA | |
54 | hsa-miR-101-5p | CACNA1E | -1.06 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.59 | 3.0E-5 | NA | |
55 | hsa-miR-125b-2-3p | CACNA1E | -1.66 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.59 | 0 | NA | |
56 | hsa-miR-148a-3p | CACNA1E | -0.75 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.55 | 2.0E-5 | NA | |
57 | hsa-miR-148a-5p | CACNA1E | -0.77 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.5 | 3.0E-5 | NA | |
58 | hsa-miR-195-3p | CACNA1E | -1.09 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.38 | 0.00021 | NA | |
59 | hsa-miR-195-5p | CACNA1E | -1.86 | 0 | 1.61 | 4.0E-5 | MirTarget | -0.44 | 0 | NA | |
60 | hsa-miR-28-5p | CACNA1E | -0.43 | 0 | 1.61 | 4.0E-5 | mirMAP | -1.04 | 0 | NA | |
61 | hsa-miR-3065-3p | CACNA1E | -1.04 | 5.0E-5 | 1.61 | 4.0E-5 | MirTarget; miRNATAP | -0.32 | 2.0E-5 | NA | |
62 | hsa-miR-30a-3p | CACNA1E | -1.53 | 0 | 1.61 | 4.0E-5 | MirTarget; mirMAP; miRNATAP | -0.61 | 0 | NA | |
63 | hsa-miR-30e-3p | CACNA1E | -1.21 | 0 | 1.61 | 4.0E-5 | MirTarget; mirMAP; miRNATAP | -0.99 | 0 | NA | |
64 | hsa-miR-3614-5p | CACNA1E | -1.66 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.37 | 4.0E-5 | NA | |
65 | hsa-miR-378a-5p | CACNA1E | -1.59 | 0 | 1.61 | 4.0E-5 | MirTarget | -0.47 | 0 | NA | |
66 | hsa-miR-424-5p | CACNA1E | -2.63 | 0 | 1.61 | 4.0E-5 | MirTarget | -0.27 | 0.00451 | NA | |
67 | hsa-miR-497-5p | CACNA1E | -1.41 | 0 | 1.61 | 4.0E-5 | MirTarget | -0.29 | 0.00879 | NA | |
68 | hsa-miR-505-3p | CACNA1E | -1.2 | 0 | 1.61 | 4.0E-5 | mirMAP | -0.4 | 0.0006 | NA | |
69 | hsa-miR-548b-3p | CACNA1E | -0.02 | 0.93082 | 1.61 | 4.0E-5 | mirMAP; miRNATAP | -0.31 | 0.0002 | NA | |
70 | hsa-miR-7-1-3p | CACNA1E | -0.57 | 2.0E-5 | 1.61 | 4.0E-5 | mirMAP | -0.5 | 0.00047 | NA | |
71 | hsa-miR-32-5p | CACNA1H | 0.08 | 0.54898 | -1.05 | 0.0092 | miRNATAP | -0.48 | 0.00125 | NA | |
72 | hsa-miR-361-3p | CACNA1H | 0.28 | 0.00549 | -1.05 | 0.0092 | MirTarget; mirMAP | -0.53 | 0.00872 | NA | |
73 | hsa-miR-326 | CACNA1I | -1.88 | 0 | 0.69 | 0.08111 | mirMAP | -0.27 | 0.0045 | NA | |
74 | hsa-miR-766-3p | CACNA1I | 0.2 | 0.25723 | 0.69 | 0.08111 | mirMAP | -0.69 | 0 | NA | |
75 | hsa-miR-92a-3p | CACNA1I | 0.21 | 0.13429 | 0.69 | 0.08111 | MirTarget; miRNATAP | -0.41 | 0.0024 | NA | |
76 | hsa-miR-34a-5p | CACNA2D2 | 1.04 | 0 | -0.35 | 0.11173 | mirMAP | -0.23 | 0.00272 | NA | |
77 | hsa-miR-193a-3p | CACNA2D3 | -0.12 | 0.30939 | 0.36 | 0.20708 | miRanda | -0.49 | 5.0E-5 | NA | |
78 | hsa-miR-28-5p | CACNA2D3 | -0.43 | 0 | 0.36 | 0.20708 | miRanda | -0.71 | 0 | NA | |
79 | hsa-miR-590-3p | CACNA2D3 | -0.47 | 2.0E-5 | 0.36 | 0.20708 | miRanda | -0.48 | 0.00016 | NA | |
80 | hsa-miR-125b-5p | CACNB1 | -1.36 | 0 | 0.94 | 0 | mirMAP; miRNATAP | -0.26 | 0 | NA | |
81 | hsa-miR-29a-5p | CACNB2 | -0.11 | 0.34962 | -0.29 | 0.15115 | MirTarget | -0.22 | 0.00914 | NA | |
82 | hsa-miR-107 | CACNB3 | 0.24 | 0.01708 | 0.96 | 0 | miRanda | -0.57 | 0 | NA | |
83 | hsa-miR-186-5p | CACNB3 | -0.06 | 0.53529 | 0.96 | 0 | miRNATAP | -0.42 | 0 | NA | |
84 | hsa-let-7b-5p | CACNB4 | -0.96 | 0 | 1.93 | 0 | miRNATAP | -0.43 | 1.0E-5 | NA | |
85 | hsa-let-7g-3p | CACNB4 | -1.14 | 0 | 1.93 | 0 | miRNATAP | -0.65 | 0 | NA | |
86 | hsa-miR-139-5p | CACNB4 | -2.11 | 0 | 1.93 | 0 | miRanda | -0.24 | 0.00059 | NA | |
87 | hsa-miR-142-5p | CACNB4 | -1.45 | 0 | 1.93 | 0 | mirMAP | -0.2 | 0.00526 | NA | |
88 | hsa-miR-144-3p | CACNB4 | -2.98 | 0 | 1.93 | 0 | mirMAP | -0.14 | 0.00449 | NA | |
89 | hsa-miR-15b-3p | CACNB4 | 0.24 | 0.09977 | 1.93 | 0 | mirMAP | -0.29 | 0.00462 | NA | |
90 | hsa-miR-16-5p | CACNB4 | -0.4 | 0.0001 | 1.93 | 0 | miRNATAP | -0.53 | 0.00021 | NA | |
91 | hsa-miR-195-5p | CACNB4 | -1.86 | 0 | 1.93 | 0 | miRNATAP | -0.41 | 0 | NA | |
92 | hsa-miR-199a-5p | CACNB4 | -1.99 | 0 | 1.93 | 0 | miRanda | -0.12 | 0.00938 | NA | |
93 | hsa-miR-20a-3p | CACNB4 | -0.32 | 0.04679 | 1.93 | 0 | miRNATAP | -0.38 | 3.0E-5 | NA | |
94 | hsa-miR-217 | CACNB4 | 1.06 | 0.0401 | 1.93 | 0 | miRanda | -0.14 | 0 | NA | |
95 | hsa-miR-26a-5p | CACNB4 | -0.96 | 0 | 1.93 | 0 | miRNATAP | -0.77 | 0 | NA | |
96 | hsa-miR-26b-5p | CACNB4 | -1.11 | 0 | 1.93 | 0 | miRNAWalker2 validate; miRNATAP | -0.42 | 0.00063 | NA | |
97 | hsa-miR-30e-5p | CACNB4 | -0.63 | 0 | 1.93 | 0 | mirMAP | -0.42 | 0.00416 | NA | |
98 | hsa-miR-330-3p | CACNB4 | -0.33 | 0.03161 | 1.93 | 0 | mirMAP | -0.29 | 0.00255 | NA | |
99 | hsa-miR-424-5p | CACNB4 | -2.63 | 0 | 1.93 | 0 | miRNATAP | -0.41 | 0 | NA | |
100 | hsa-miR-497-5p | CACNB4 | -1.41 | 0 | 1.93 | 0 | miRNATAP | -0.46 | 0 | NA | |
101 | hsa-miR-505-3p | CACNB4 | -1.2 | 0 | 1.93 | 0 | miRNATAP | -0.38 | 2.0E-5 | NA | |
102 | hsa-miR-542-3p | CACNB4 | -1.31 | 0 | 1.93 | 0 | miRanda | -0.32 | 0.00165 | NA | |
103 | hsa-miR-92a-3p | CACNB4 | 0.21 | 0.13429 | 1.93 | 0 | mirMAP | -0.38 | 0.00026 | NA | |
104 | hsa-let-7b-3p | CACNG4 | -1.22 | 0 | 1.21 | 0.01585 | MirTarget | -0.53 | 0.00108 | NA | |
105 | hsa-miR-29a-3p | CACNG4 | -0.86 | 0 | 1.21 | 0.01585 | miRNATAP | -0.93 | 0 | NA | |
106 | hsa-miR-29c-3p | CACNG4 | -1.44 | 0 | 1.21 | 0.01585 | miRNATAP | -0.69 | 1.0E-5 | NA | |
107 | hsa-let-7g-5p | CASP3 | -0.46 | 2.0E-5 | 0.31 | 0.00047 | MirTarget; miRNATAP | -0.11 | 0.00694 | NA | |
108 | hsa-miR-374b-5p | CASP3 | -0.31 | 0.00301 | 0.31 | 0.00047 | mirMAP | -0.14 | 0.00058 | NA | |
109 | hsa-let-7a-5p | CDC25B | -0.33 | 0.00046 | 0.8 | 0 | miRNAWalker2 validate | -0.21 | 0.00571 | NA | |
110 | hsa-miR-148a-3p | CDC25B | -0.75 | 0 | 0.8 | 0 | miRNAWalker2 validate; miRNATAP | -0.29 | 0 | 25341915 | Gene CDC25B might be the target gene of miR-148a according to the results of targetscan; CDC25B may be the target gene of miR-148a that plays a role in tumor suppressor |
111 | hsa-miR-204-5p | CDC25B | -0.54 | 0.03309 | 0.8 | 0 | miRNATAP | -0.16 | 0 | NA | |
112 | hsa-miR-26b-5p | CDC25B | -1.11 | 0 | 0.8 | 0 | miRNAWalker2 validate | -0.28 | 0 | NA | |
113 | hsa-miR-27b-3p | CDC25B | -0.82 | 0 | 0.8 | 0 | miRNATAP | -0.3 | 0 | NA | |
114 | hsa-miR-15a-5p | CHUK | 0.35 | 0.00077 | -0.2 | 0.00863 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.12 | 0.00057 | NA | |
115 | hsa-miR-15b-5p | CHUK | 0.23 | 0.08248 | -0.2 | 0.00863 | MirTarget | -0.12 | 2.0E-5 | NA | |
116 | hsa-miR-16-5p | CHUK | -0.4 | 0.0001 | -0.2 | 0.00863 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.15 | 3.0E-5 | NA | |
117 | hsa-miR-23a-3p | CHUK | -0.18 | 0.13598 | -0.2 | 0.00863 | MirTarget | -0.1 | 0.00114 | NA | |
118 | hsa-miR-339-5p | CHUK | 0.28 | 0.03557 | -0.2 | 0.00863 | miRanda | -0.12 | 1.0E-5 | NA | |
119 | hsa-miR-590-5p | CHUK | -0.1 | 0.31003 | -0.2 | 0.00863 | miRanda | -0.12 | 0.00129 | NA | |
120 | hsa-miR-106b-3p | CRK | 0.3 | 0.01182 | -0.66 | 0 | miRNAWalker2 validate | -0.16 | 0.00019 | NA | |
121 | hsa-miR-106b-5p | CRK | 0.65 | 0 | -0.66 | 0 | MirTarget; miRNATAP | -0.3 | 0 | NA | |
122 | hsa-miR-15b-5p | CRK | 0.23 | 0.08248 | -0.66 | 0 | miRNAWalker2 validate | -0.24 | 0 | NA | |
123 | hsa-miR-17-5p | CRK | 0.7 | 2.0E-5 | -0.66 | 0 | MirTarget; TargetScan; miRNATAP | -0.12 | 9.0E-5 | NA | |
124 | hsa-miR-186-5p | CRK | -0.06 | 0.53529 | -0.66 | 0 | miRNATAP | -0.25 | 0 | NA | |
125 | hsa-miR-20a-5p | CRK | 0.85 | 0 | -0.66 | 0 | MirTarget; miRNATAP | -0.12 | 5.0E-5 | NA | |
126 | hsa-miR-20b-5p | CRK | 0.46 | 0.02859 | -0.66 | 0 | MirTarget; miRNATAP | -0.1 | 2.0E-5 | NA | |
127 | hsa-miR-361-5p | CRK | 0.23 | 0.00962 | -0.66 | 0 | miRanda; mirMAP | -0.3 | 0 | NA | |
128 | hsa-miR-362-3p | CRK | 0.81 | 0 | -0.66 | 0 | miRanda | -0.18 | 0 | NA | |
129 | hsa-miR-589-3p | CRK | 1.17 | 0 | -0.66 | 0 | MirTarget | -0.18 | 0 | NA | |
130 | hsa-miR-93-5p | CRK | 1.4 | 0 | -0.66 | 0 | MirTarget; miRNATAP | -0.26 | 0 | NA | |
131 | hsa-miR-29a-3p | CRKL | -0.86 | 0 | 0.1 | 0.19946 | miRNAWalker2 validate | -0.13 | 2.0E-5 | NA | |
132 | hsa-miR-497-5p | CRKL | -1.41 | 0 | 0.1 | 0.19946 | MirTarget; miRNATAP | -0.11 | 0 | NA | |
133 | hsa-miR-335-5p | DDIT3 | -1.61 | 0 | 0.75 | 0 | miRNAWalker2 validate | -0.12 | 0.00119 | NA | |
134 | hsa-miR-542-3p | DDIT3 | -1.31 | 0 | 0.75 | 0 | miRanda | -0.14 | 0.00368 | NA | |
135 | hsa-miR-200c-3p | DUSP1 | -0.1 | 0.71696 | -2.02 | 0 | MirTarget; miRNATAP | -0.1 | 0.00452 | NA | |
136 | hsa-miR-324-3p | DUSP1 | 0.26 | 0.05061 | -2.02 | 0 | MirTarget | -0.52 | 0 | NA | |
137 | hsa-miR-331-5p | DUSP1 | 0.21 | 0.12077 | -2.02 | 0 | PITA; miRNATAP | -0.29 | 0.00017 | NA | |
138 | hsa-miR-425-3p | DUSP1 | -0.16 | 0.22372 | -2.02 | 0 | MirTarget | -0.33 | 7.0E-5 | NA | |
139 | hsa-miR-21-5p | DUSP10 | 1.51 | 0 | -1.25 | 0 | miRNAWalker2 validate; miRTarBase | -0.34 | 0 | NA | |
140 | hsa-miR-25-3p | DUSP10 | 0.63 | 0 | -1.25 | 0 | MirTarget; miRNATAP | -0.32 | 3.0E-5 | NA | |
141 | hsa-miR-421 | DUSP10 | 0.94 | 0 | -1.25 | 0 | PITA; miRanda; miRNATAP | -0.26 | 0 | NA | |
142 | hsa-miR-501-5p | DUSP10 | 1.15 | 0 | -1.25 | 0 | PITA; miRNATAP | -0.2 | 0 | NA | |
143 | hsa-miR-92b-3p | DUSP10 | 0.22 | 0.29619 | -1.25 | 0 | MirTarget; miRNATAP | -0.13 | 0.00029 | NA | |
144 | hsa-miR-942-5p | DUSP10 | 0.35 | 0.02833 | -1.25 | 0 | MirTarget | -0.16 | 0.00118 | NA | |
145 | hsa-miR-589-5p | DUSP14 | 1.19 | 0 | -1 | 0 | MirTarget | -0.16 | 0.00015 | NA | |
146 | hsa-let-7e-5p | DUSP16 | 0.04 | 0.81107 | -0.91 | 0 | miRNATAP | -0.13 | 0.003 | NA | |
147 | hsa-let-7i-5p | DUSP16 | -0.14 | 0.15414 | -0.91 | 0 | miRNATAP | -0.2 | 0.00216 | NA | |
148 | hsa-miR-103a-2-5p | DUSP16 | 1.17 | 0 | -0.91 | 0 | mirMAP | -0.18 | 0 | NA | |
149 | hsa-miR-125a-3p | DUSP16 | -0.84 | 4.0E-5 | -0.91 | 0 | miRanda | -0.12 | 0.00013 | NA | |
150 | hsa-miR-140-5p | DUSP16 | -0.22 | 0.01407 | -0.91 | 0 | miRNATAP | -0.2 | 0.00767 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 78 | 404 | 3.181e-86 | 1.48e-82 |
2 | INTRACELLULAR SIGNAL TRANSDUCTION | 111 | 1572 | 9.784e-79 | 2.276e-75 |
3 | PROTEIN PHOSPHORYLATION | 93 | 944 | 1.557e-76 | 2.415e-73 |
4 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 117 | 1977 | 1.689e-75 | 1.965e-72 |
5 | REGULATION OF MAPK CASCADE | 81 | 660 | 4.446e-73 | 4.137e-70 |
6 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 107 | 1656 | 4.469e-71 | 3.466e-68 |
7 | REGULATION OF MAP KINASE ACTIVITY | 62 | 319 | 1.763e-67 | 1.172e-64 |
8 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 84 | 876 | 5.237e-67 | 3.046e-64 |
9 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 109 | 1929 | 1.293e-66 | 6.684e-64 |
10 | PHOSPHORYLATION | 93 | 1228 | 5.965e-66 | 2.775e-63 |
11 | POSITIVE REGULATION OF MAPK CASCADE | 68 | 470 | 3.135e-65 | 1.326e-62 |
12 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 67 | 470 | 9.611e-64 | 3.727e-61 |
13 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 86 | 1036 | 1.743e-63 | 5.69e-61 |
14 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 86 | 1036 | 1.743e-63 | 5.69e-61 |
15 | REGULATION OF PROTEIN MODIFICATION PROCESS | 102 | 1710 | 1.834e-63 | 5.69e-61 |
16 | REGULATION OF KINASE ACTIVITY | 78 | 776 | 3.477e-63 | 1.011e-60 |
17 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 99 | 1618 | 3.492e-62 | 9.557e-60 |
18 | POSITIVE REGULATION OF KINASE ACTIVITY | 65 | 482 | 4.537e-60 | 1.173e-57 |
19 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 85 | 1135 | 6.782e-59 | 1.661e-56 |
20 | POSITIVE REGULATION OF CELL COMMUNICATION | 94 | 1532 | 1.92e-58 | 4.467e-56 |
21 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 99 | 1791 | 5.451e-58 | 1.208e-55 |
22 | REGULATION OF TRANSFERASE ACTIVITY | 79 | 946 | 8.95e-58 | 1.893e-55 |
23 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 90 | 1492 | 8.344e-55 | 1.688e-52 |
24 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 89 | 1518 | 5.035e-53 | 9.394e-51 |
25 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 65 | 616 | 5.047e-53 | 9.394e-51 |
26 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 47 | 279 | 2.073e-47 | 3.71e-45 |
27 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 45 | 289 | 1.005e-43 | 1.732e-41 |
28 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 37 | 207 | 3.564e-38 | 5.923e-36 |
29 | STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 29 | 103 | 3.049e-36 | 4.892e-34 |
30 | REGULATION OF RESPONSE TO STRESS | 70 | 1468 | 2.507e-34 | 3.889e-32 |
31 | REGULATION OF CELL DEATH | 67 | 1472 | 1.875e-31 | 2.815e-29 |
32 | RESPONSE TO GROWTH FACTOR | 42 | 475 | 2.324e-30 | 3.379e-28 |
33 | JNK CASCADE | 23 | 82 | 7.76e-29 | 1.094e-26 |
34 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 30 | 197 | 8.552e-29 | 1.17e-26 |
35 | REGULATION OF IMMUNE SYSTEM PROCESS | 60 | 1403 | 2.125e-26 | 2.825e-24 |
36 | ACTIVATION OF MAPK ACTIVITY | 25 | 137 | 3.724e-26 | 4.813e-24 |
37 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 44 | 689 | 6.359e-26 | 7.997e-24 |
38 | CELL DEATH | 51 | 1001 | 1.281e-25 | 1.569e-23 |
39 | REGULATION OF JNK CASCADE | 25 | 159 | 1.85e-24 | 2.207e-22 |
40 | REGULATION OF IMMUNE RESPONSE | 46 | 858 | 6.306e-24 | 7.285e-22 |
41 | CELLULAR RESPONSE TO STRESS | 60 | 1565 | 6.419e-24 | 7.285e-22 |
42 | RESPONSE TO EXTERNAL STIMULUS | 64 | 1821 | 1.295e-23 | 1.435e-21 |
43 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 31 | 323 | 1.723e-23 | 1.865e-21 |
44 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 23 | 135 | 2.096e-23 | 2.217e-21 |
45 | ACTIVATION OF MAPKK ACTIVITY | 17 | 52 | 7.115e-23 | 7.357e-21 |
46 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 63 | 1848 | 1.685e-22 | 1.684e-20 |
47 | RESPONSE TO ABIOTIC STIMULUS | 48 | 1024 | 1.701e-22 | 1.684e-20 |
48 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 62 | 1805 | 2.829e-22 | 2.742e-20 |
49 | POSITIVE REGULATION OF CELL DEATH | 38 | 605 | 4.29e-22 | 4.074e-20 |
50 | REGULATION OF CELLULAR RESPONSE TO STRESS | 40 | 691 | 5.839e-22 | 5.434e-20 |
51 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 35 | 498 | 6.023e-22 | 5.495e-20 |
52 | POSITIVE REGULATION OF GENE EXPRESSION | 59 | 1733 | 6.657e-21 | 5.956e-19 |
53 | REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 30 | 365 | 8.498e-21 | 7.461e-19 |
54 | REGULATION OF TRANSPORT | 60 | 1804 | 8.773e-21 | 7.56e-19 |
55 | REGULATION OF HYDROLASE ACTIVITY | 51 | 1327 | 3.857e-20 | 3.205e-18 |
56 | REGULATION OF CELL PROLIFERATION | 54 | 1496 | 3.789e-20 | 3.205e-18 |
57 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 21 | 142 | 4.133e-20 | 3.374e-18 |
58 | RESPONSE TO ENDOGENOUS STIMULUS | 53 | 1450 | 5.391e-20 | 4.325e-18 |
59 | PROTEIN AUTOPHOSPHORYLATION | 23 | 192 | 8.435e-20 | 6.652e-18 |
60 | PEPTIDYL SERINE MODIFICATION | 21 | 148 | 1.008e-19 | 7.813e-18 |
61 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 42 | 905 | 1.858e-19 | 1.418e-17 |
62 | FC RECEPTOR SIGNALING PATHWAY | 23 | 206 | 4.234e-19 | 3.177e-17 |
63 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 46 | 1142 | 6.827e-19 | 5.042e-17 |
64 | REGULATION OF CELL DIFFERENTIATION | 52 | 1492 | 1.074e-18 | 7.805e-17 |
65 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 50 | 1381 | 1.243e-18 | 8.9e-17 |
66 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 43 | 1008 | 1.481e-18 | 1.044e-16 |
67 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 40 | 867 | 1.958e-18 | 1.36e-16 |
68 | PEPTIDYL AMINO ACID MODIFICATION | 39 | 841 | 4.748e-18 | 3.249e-16 |
69 | NEGATIVE REGULATION OF CELL DEATH | 39 | 872 | 1.627e-17 | 1.097e-15 |
70 | RAS PROTEIN SIGNAL TRANSDUCTION | 19 | 143 | 2.166e-17 | 1.44e-15 |
71 | REGULATION OF NEURON DEATH | 23 | 252 | 3.963e-17 | 2.597e-15 |
72 | POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 20 | 172 | 4.36e-17 | 2.818e-15 |
73 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 26 | 352 | 5.674e-17 | 3.617e-15 |
74 | POSITIVE REGULATION OF CELL PROLIFERATION | 37 | 814 | 7.518e-17 | 4.727e-15 |
75 | INACTIVATION OF MAPK ACTIVITY | 11 | 26 | 1.084e-16 | 6.723e-15 |
76 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 47 | 1360 | 1.1e-16 | 6.734e-15 |
77 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 52 | 1672 | 1.377e-16 | 8.324e-15 |
78 | REGULATION OF ERK1 AND ERK2 CASCADE | 22 | 238 | 1.528e-16 | 9.112e-15 |
79 | REGULATION OF NEURON APOPTOTIC PROCESS | 20 | 192 | 3.842e-16 | 2.263e-14 |
80 | NEGATIVE REGULATION OF CELL COMMUNICATION | 43 | 1192 | 6.657e-16 | 3.872e-14 |
81 | CELL DEVELOPMENT | 47 | 1426 | 6.824e-16 | 3.92e-14 |
82 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 36 | 823 | 6.988e-16 | 3.966e-14 |
83 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 35 | 788 | 1.19e-15 | 6.59e-14 |
84 | CIRCULATORY SYSTEM DEVELOPMENT | 35 | 788 | 1.19e-15 | 6.59e-14 |
85 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 46 | 1395 | 1.487e-15 | 8.14e-14 |
86 | IMMUNE SYSTEM PROCESS | 55 | 1984 | 2.037e-15 | 1.102e-13 |
87 | REGULATION OF DEFENSE RESPONSE | 34 | 759 | 2.525e-15 | 1.351e-13 |
88 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 39 | 1021 | 3.109e-15 | 1.644e-13 |
89 | VASCULATURE DEVELOPMENT | 27 | 469 | 6.68e-15 | 3.492e-13 |
90 | LOCOMOTION | 40 | 1114 | 9.992e-15 | 5.166e-13 |
91 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 38 | 1004 | 1.011e-14 | 5.172e-13 |
92 | POSITIVE REGULATION OF IMMUNE RESPONSE | 29 | 563 | 1.071e-14 | 5.416e-13 |
93 | REGULATION OF GTPASE ACTIVITY | 31 | 673 | 2.409e-14 | 1.205e-12 |
94 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 33 | 771 | 2.514e-14 | 1.244e-12 |
95 | TISSUE DEVELOPMENT | 46 | 1518 | 3.37e-14 | 1.651e-12 |
96 | POSITIVE REGULATION OF LOCOMOTION | 25 | 420 | 3.453e-14 | 1.674e-12 |
97 | TUBE DEVELOPMENT | 28 | 552 | 4.745e-14 | 2.276e-12 |
98 | ORGAN MORPHOGENESIS | 34 | 841 | 4.987e-14 | 2.368e-12 |
99 | NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 13 | 73 | 5.703e-14 | 2.68e-12 |
100 | PROTEIN DEPHOSPHORYLATION | 18 | 190 | 6.513e-14 | 3.03e-12 |
101 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 18 | 193 | 8.557e-14 | 3.942e-12 |
102 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 38 | 1079 | 9.744e-14 | 4.445e-12 |
103 | POSITIVE REGULATION OF DEFENSE RESPONSE | 23 | 364 | 1.136e-13 | 5.132e-12 |
104 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 16 | 144 | 1.406e-13 | 6.289e-12 |
105 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 39 | 1152 | 1.512e-13 | 6.7e-12 |
106 | NEGATIVE REGULATION OF MAPK CASCADE | 16 | 145 | 1.568e-13 | 6.884e-12 |
107 | POSITIVE REGULATION OF TRANSPORT | 35 | 936 | 1.961e-13 | 8.529e-12 |
108 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 27 | 541 | 2.077e-13 | 8.867e-12 |
109 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 27 | 541 | 2.077e-13 | 8.867e-12 |
110 | REGULATION OF ORGANELLE ORGANIZATION | 39 | 1178 | 3.057e-13 | 1.293e-11 |
111 | REGULATION OF TRANSMEMBRANE TRANSPORT | 24 | 426 | 3.86e-13 | 1.618e-11 |
112 | ACTIVATION OF IMMUNE RESPONSE | 24 | 427 | 4.059e-13 | 1.686e-11 |
113 | REGULATION OF CYTOKINE PRODUCTION | 27 | 563 | 5.331e-13 | 2.176e-11 |
114 | RESPONSE TO WOUNDING | 27 | 563 | 5.331e-13 | 2.176e-11 |
115 | POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 15 | 132 | 5.996e-13 | 2.415e-11 |
116 | PEPTIDYL TYROSINE MODIFICATION | 17 | 186 | 6.02e-13 | 2.415e-11 |
117 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 24 | 437 | 6.676e-13 | 2.655e-11 |
118 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 21 | 321 | 7.343e-13 | 2.896e-11 |
119 | CELL CELL SIGNALING | 31 | 767 | 7.72e-13 | 3.018e-11 |
120 | REGULATION OF CELLULAR LOCALIZATION | 40 | 1277 | 8.346e-13 | 3.236e-11 |
121 | APOPTOTIC SIGNALING PATHWAY | 20 | 289 | 9.483e-13 | 3.647e-11 |
122 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 15 | 138 | 1.159e-12 | 4.42e-11 |
123 | POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 18 | 228 | 1.506e-12 | 5.696e-11 |
124 | REGULATION OF ION TRANSPORT | 27 | 592 | 1.729e-12 | 6.489e-11 |
125 | WOUND HEALING | 24 | 470 | 3.148e-12 | 1.172e-10 |
126 | PEPTIDYL TYROSINE DEPHOSPHORYLATION | 13 | 100 | 3.838e-12 | 1.417e-10 |
127 | INOSITOL LIPID MEDIATED SIGNALING | 14 | 124 | 3.981e-12 | 1.459e-10 |
128 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 34 | 983 | 4.045e-12 | 1.471e-10 |
129 | RESPONSE TO MECHANICAL STIMULUS | 17 | 210 | 4.327e-12 | 1.556e-10 |
130 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 27 | 616 | 4.348e-12 | 1.556e-10 |
131 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 14 | 126 | 4.969e-12 | 1.765e-10 |
132 | REGULATION OF JUN KINASE ACTIVITY | 12 | 81 | 5.392e-12 | 1.901e-10 |
133 | REGULATION OF INNATE IMMUNE RESPONSE | 21 | 357 | 5.615e-12 | 1.964e-10 |
134 | POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 14 | 128 | 6.176e-12 | 2.145e-10 |
135 | RESPONSE TO BIOTIC STIMULUS | 32 | 886 | 6.223e-12 | 2.145e-10 |
136 | MORPHOGENESIS OF AN EPITHELIUM | 22 | 400 | 6.384e-12 | 2.184e-10 |
137 | POSITIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 63 | 6.543e-12 | 2.222e-10 |
138 | RESPONSE TO LIPID | 32 | 888 | 6.602e-12 | 2.226e-10 |
139 | EPITHELIUM DEVELOPMENT | 33 | 945 | 6.837e-12 | 2.289e-10 |
140 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 21 | 363 | 7.699e-12 | 2.559e-10 |
141 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 11 | 64 | 7.842e-12 | 2.588e-10 |
142 | INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 13 | 106 | 8.21e-12 | 2.69e-10 |
143 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 46 | 1784 | 1.032e-11 | 3.358e-10 |
144 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 30 | 799 | 1.202e-11 | 3.857e-10 |
145 | RESPONSE TO RADIATION | 22 | 413 | 1.194e-11 | 3.857e-10 |
146 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 35 | 1087 | 1.383e-11 | 4.406e-10 |
147 | RESPONSE TO NITROGEN COMPOUND | 31 | 859 | 1.427e-11 | 4.515e-10 |
148 | GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 19 | 297 | 1.436e-11 | 4.515e-10 |
149 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 38 | 1275 | 1.554e-11 | 4.853e-10 |
150 | TAXIS | 23 | 464 | 1.689e-11 | 5.239e-10 |
151 | NEGATIVE REGULATION OF PHOSPHORYLATION | 22 | 422 | 1.818e-11 | 5.601e-10 |
152 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 10 | 53 | 2.704e-11 | 8.278e-10 |
153 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 30 | 829 | 2.984e-11 | 9.074e-10 |
154 | ACTIVATION OF INNATE IMMUNE RESPONSE | 16 | 204 | 3.065e-11 | 9.26e-10 |
155 | REGULATION OF INTRACELLULAR TRANSPORT | 26 | 621 | 3.117e-11 | 9.357e-10 |
156 | RESPONSE TO BACTERIUM | 24 | 528 | 3.586e-11 | 1.069e-09 |
157 | REGULATION OF CELL CYCLE | 32 | 949 | 3.705e-11 | 1.098e-09 |
158 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 12 | 95 | 3.751e-11 | 1.105e-09 |
159 | REGULATION OF PROTEIN LOCALIZATION | 32 | 950 | 3.806e-11 | 1.114e-09 |
160 | REGULATION OF CELL ACTIVATION | 23 | 484 | 3.936e-11 | 1.131e-09 |
161 | EMBRYO DEVELOPMENT | 31 | 894 | 3.909e-11 | 1.131e-09 |
162 | POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 9 | 39 | 3.928e-11 | 1.131e-09 |
163 | REGULATION OF CALCIUM ION TRANSPORT | 16 | 209 | 4.414e-11 | 1.26e-09 |
164 | POSITIVE REGULATION OF INNATE IMMUNE RESPONSE | 17 | 246 | 5.378e-11 | 1.526e-09 |
165 | LIPID PHOSPHORYLATION | 12 | 99 | 6.156e-11 | 1.736e-09 |
166 | BLOOD VESSEL MORPHOGENESIS | 20 | 364 | 6.313e-11 | 1.769e-09 |
167 | DEPHOSPHORYLATION | 18 | 286 | 6.658e-11 | 1.855e-09 |
168 | NEGATIVE REGULATION OF KINASE ACTIVITY | 17 | 250 | 6.929e-11 | 1.919e-09 |
169 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 15 | 184 | 7.522e-11 | 2.071e-09 |
170 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 14 | 154 | 7.692e-11 | 2.105e-09 |
171 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 31 | 926 | 9.403e-11 | 2.559e-09 |
172 | CALCIUM ION TRANSPORT | 16 | 223 | 1.165e-10 | 3.151e-09 |
173 | MEMBRANE DEPOLARIZATION | 10 | 61 | 1.178e-10 | 3.16e-09 |
174 | CALCIUM ION TRANSMEMBRANE TRANSPORT | 14 | 159 | 1.182e-10 | 3.16e-09 |
175 | HEART DEVELOPMENT | 22 | 466 | 1.227e-10 | 3.263e-09 |
176 | REGULATION OF LIPASE ACTIVITY | 11 | 83 | 1.476e-10 | 3.903e-09 |
177 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 14 | 162 | 1.518e-10 | 3.991e-09 |
178 | CELL MOTILITY | 29 | 835 | 1.756e-10 | 4.565e-09 |
179 | LOCALIZATION OF CELL | 29 | 835 | 1.756e-10 | 4.565e-09 |
180 | ACTIVATION OF MAPKKK ACTIVITY | 6 | 11 | 1.772e-10 | 4.582e-09 |
181 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 46 | 1.938e-10 | 4.983e-09 |
182 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 31 | 957 | 2.121e-10 | 5.423e-09 |
183 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 11 | 86 | 2.188e-10 | 5.563e-09 |
184 | REGULATION OF CELL ADHESION | 25 | 629 | 2.315e-10 | 5.854e-09 |
185 | POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 9 | 47 | 2.38e-10 | 5.985e-09 |
186 | SALIVARY GLAND DEVELOPMENT | 8 | 32 | 2.458e-10 | 6.15e-09 |
187 | IMMUNE SYSTEM DEVELOPMENT | 24 | 582 | 2.62e-10 | 6.52e-09 |
188 | POSITIVE REGULATION OF LIPASE ACTIVITY | 10 | 66 | 2.655e-10 | 6.57e-09 |
189 | POSITIVE REGULATION OF NEURON DEATH | 10 | 67 | 3.097e-10 | 7.625e-09 |
190 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 14 | 171 | 3.121e-10 | 7.642e-09 |
191 | GLYCEROLIPID METABOLIC PROCESS | 19 | 356 | 3.194e-10 | 7.781e-09 |
192 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 17 | 278 | 3.616e-10 | 8.764e-09 |
193 | RESPONSE TO LIGHT STIMULUS | 17 | 280 | 4.039e-10 | 9.737e-09 |
194 | NEURON PROJECTION DEVELOPMENT | 23 | 545 | 4.085e-10 | 9.797e-09 |
195 | REGULATION OF LIPID METABOLIC PROCESS | 17 | 282 | 4.507e-10 | 1.075e-08 |
196 | PHOSPHOLIPID METABOLIC PROCESS | 19 | 364 | 4.64e-10 | 1.102e-08 |
197 | TUBE MORPHOGENESIS | 18 | 323 | 4.808e-10 | 1.136e-08 |
198 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 17 | 285 | 5.303e-10 | 1.246e-08 |
199 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 27 | 767 | 6.028e-10 | 1.41e-08 |
200 | PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 7 | 23 | 7.286e-10 | 1.695e-08 |
201 | REGULATION OF ORGAN GROWTH | 10 | 73 | 7.419e-10 | 1.717e-08 |
202 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 22 | 514 | 7.794e-10 | 1.795e-08 |
203 | REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 13 | 152 | 7.997e-10 | 1.833e-08 |
204 | RESPONSE TO HORMONE | 29 | 893 | 8.338e-10 | 1.902e-08 |
205 | POSITIVE REGULATION OF DNA METABOLIC PROCESS | 14 | 185 | 8.82e-10 | 2.002e-08 |
206 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 18 | 337 | 9.485e-10 | 2.139e-08 |
207 | REGULATION OF CELL CELL ADHESION | 19 | 380 | 9.517e-10 | 2.139e-08 |
208 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 11 | 99 | 1.023e-09 | 2.287e-08 |
209 | RESPONSE TO DRUG | 20 | 431 | 1.223e-09 | 2.71e-08 |
210 | MODULATION OF SYNAPTIC TRANSMISSION | 17 | 301 | 1.222e-09 | 2.71e-08 |
211 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 16 | 263 | 1.317e-09 | 2.904e-08 |
212 | REGULATION OF CYTOPLASMIC TRANSPORT | 21 | 481 | 1.37e-09 | 3.006e-08 |
213 | NEURON DEVELOPMENT | 25 | 687 | 1.428e-09 | 3.119e-08 |
214 | TISSUE MORPHOGENESIS | 22 | 533 | 1.529e-09 | 3.325e-08 |
215 | DIVALENT INORGANIC CATION TRANSPORT | 16 | 268 | 1.729e-09 | 3.743e-08 |
216 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 18 | 351 | 1.811e-09 | 3.901e-08 |
217 | CELLULAR RESPONSE TO MECHANICAL STIMULUS | 10 | 80 | 1.866e-09 | 4.001e-08 |
218 | RESPONSE TO OXIDATIVE STRESS | 18 | 352 | 1.894e-09 | 4.043e-08 |
219 | PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 7 | 26 | 1.913e-09 | 4.064e-08 |
220 | REGULATION OF FIBROBLAST PROLIFERATION | 10 | 81 | 2.113e-09 | 4.468e-08 |
221 | REGULATION OF TRANSPORTER ACTIVITY | 14 | 198 | 2.141e-09 | 4.508e-08 |
222 | NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 12 | 135 | 2.35e-09 | 4.926e-08 |
223 | REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 166 | 2.369e-09 | 4.943e-08 |
224 | CARDIAC CONDUCTION | 10 | 82 | 2.388e-09 | 4.961e-08 |
225 | ACTIN FILAMENT BASED PROCESS | 20 | 450 | 2.564e-09 | 5.303e-08 |
226 | HEAD DEVELOPMENT | 25 | 709 | 2.707e-09 | 5.574e-08 |
227 | PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING | 6 | 16 | 2.963e-09 | 6.074e-08 |
228 | NEGATIVE REGULATION OF NEURON DEATH | 13 | 171 | 3.405e-09 | 6.948e-08 |
229 | REGULATION OF BINDING | 16 | 283 | 3.786e-09 | 7.692e-08 |
230 | REGULATION OF METAL ION TRANSPORT | 17 | 325 | 3.895e-09 | 7.879e-08 |
231 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 7 | 29 | 4.439e-09 | 8.942e-08 |
232 | PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 6 | 17 | 4.546e-09 | 9.04e-08 |
233 | CELL PROLIFERATION | 24 | 672 | 4.536e-09 | 9.04e-08 |
234 | PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 6 | 17 | 4.546e-09 | 9.04e-08 |
235 | EXOCRINE SYSTEM DEVELOPMENT | 8 | 45 | 4.576e-09 | 9.06e-08 |
236 | GLYCEROLIPID BIOSYNTHETIC PROCESS | 14 | 211 | 4.873e-09 | 9.607e-08 |
237 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 14 | 213 | 5.501e-09 | 1.08e-07 |
238 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 22 | 573 | 5.759e-09 | 1.126e-07 |
239 | ANGIOGENESIS | 16 | 293 | 6.214e-09 | 1.21e-07 |
240 | REGULATION OF GROWTH | 23 | 633 | 7.112e-09 | 1.379e-07 |
241 | PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 7 | 31 | 7.371e-09 | 1.422e-07 |
242 | RESPONSE TO INORGANIC SUBSTANCE | 20 | 479 | 7.395e-09 | 1.422e-07 |
243 | REGULATION OF PROTEIN IMPORT | 13 | 183 | 7.753e-09 | 1.484e-07 |
244 | REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 8 | 48 | 7.835e-09 | 1.494e-07 |
245 | RHYTHMIC PROCESS | 16 | 298 | 7.902e-09 | 1.501e-07 |
246 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 14 | 220 | 8.324e-09 | 1.575e-07 |
247 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 11 | 121 | 8.783e-09 | 1.654e-07 |
248 | POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 7 | 32 | 9.366e-09 | 1.757e-07 |
249 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 27 | 872 | 9.432e-09 | 1.763e-07 |
250 | I KAPPAB KINASE NF KAPPAB SIGNALING | 9 | 70 | 9.57e-09 | 1.781e-07 |
251 | REGULATION OF SECRETION | 24 | 699 | 9.717e-09 | 1.801e-07 |
252 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 12 | 153 | 9.797e-09 | 1.809e-07 |
253 | NEURON DIFFERENTIATION | 27 | 874 | 9.897e-09 | 1.82e-07 |
254 | MULTICELLULAR ORGANISMAL SIGNALING | 11 | 123 | 1.044e-08 | 1.913e-07 |
255 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 15 | 264 | 1.111e-08 | 2.028e-07 |
256 | GLAND DEVELOPMENT | 18 | 395 | 1.148e-08 | 2.086e-07 |
257 | REGULATION OF HOMOTYPIC CELL CELL ADHESION | 16 | 307 | 1.204e-08 | 2.179e-07 |
258 | NEUROGENESIS | 35 | 1402 | 1.216e-08 | 2.188e-07 |
259 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 13 | 190 | 1.218e-08 | 2.188e-07 |
260 | GLAND MORPHOGENESIS | 10 | 97 | 1.255e-08 | 2.246e-07 |
261 | REGULATION OF CELL MORPHOGENESIS | 21 | 552 | 1.541e-08 | 2.747e-07 |
262 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 8 | 53 | 1.773e-08 | 3.145e-07 |
263 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 17 | 360 | 1.778e-08 | 3.145e-07 |
264 | CELL PROJECTION ORGANIZATION | 27 | 902 | 1.911e-08 | 3.369e-07 |
265 | PHOSPHOLIPID BIOSYNTHETIC PROCESS | 14 | 235 | 1.925e-08 | 3.379e-07 |
266 | POSITIVE REGULATION OF CELL DIVISION | 11 | 132 | 2.192e-08 | 3.835e-07 |
267 | POSITIVE REGULATION OF GROWTH | 14 | 238 | 2.259e-08 | 3.922e-07 |
268 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 10 | 103 | 2.251e-08 | 3.922e-07 |
269 | REGULATION OF RESPONSE TO WOUNDING | 18 | 413 | 2.276e-08 | 3.937e-07 |
270 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 12 | 167 | 2.62e-08 | 4.515e-07 |
271 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 17 | 370 | 2.656e-08 | 4.56e-07 |
272 | STRIATED MUSCLE CELL DIFFERENTIATION | 12 | 173 | 3.88e-08 | 6.638e-07 |
273 | LIPID MODIFICATION | 13 | 210 | 4.011e-08 | 6.836e-07 |
274 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 7 | 39 | 4.066e-08 | 6.883e-07 |
275 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 17 | 381 | 4.068e-08 | 6.883e-07 |
276 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 13 | 211 | 4.242e-08 | 7.151e-07 |
277 | MUSCLE STRUCTURE DEVELOPMENT | 18 | 432 | 4.51e-08 | 7.577e-07 |
278 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 40 | 4.893e-08 | 8.159e-07 |
279 | FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 84 | 4.881e-08 | 8.159e-07 |
280 | REGULATION OF DNA METABOLIC PROCESS | 16 | 340 | 5.004e-08 | 8.316e-07 |
281 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 15 | 296 | 5.082e-08 | 8.416e-07 |
282 | EMBRYONIC MORPHOGENESIS | 20 | 539 | 5.237e-08 | 8.641e-07 |
283 | REGULATION OF PROTEIN SECRETION | 17 | 389 | 5.495e-08 | 9.035e-07 |
284 | REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 8 | 61 | 5.554e-08 | 9.1e-07 |
285 | POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 12 | 179 | 5.66e-08 | 9.241e-07 |
286 | POSITIVE REGULATION OF DNA REPLICATION | 9 | 86 | 6.008e-08 | 9.774e-07 |
287 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 14 | 258 | 6.203e-08 | 1.006e-06 |
288 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 13 | 218 | 6.228e-08 | 1.006e-06 |
289 | SENSORY ORGAN DEVELOPMENT | 19 | 493 | 6.396e-08 | 1.03e-06 |
290 | POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 7 | 42 | 6.977e-08 | 1.112e-06 |
291 | REGULATION OF HEART GROWTH | 7 | 42 | 6.977e-08 | 1.112e-06 |
292 | REGULATION OF CELL DEVELOPMENT | 25 | 836 | 6.958e-08 | 1.112e-06 |
293 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 10 | 116 | 7.063e-08 | 1.118e-06 |
294 | RESPONSE TO FIBROBLAST GROWTH FACTOR | 10 | 116 | 7.063e-08 | 1.118e-06 |
295 | CELLULAR COMPONENT MORPHOGENESIS | 26 | 900 | 7.323e-08 | 1.155e-06 |
296 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 9 | 88 | 7.354e-08 | 1.156e-06 |
297 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 20 | 552 | 7.719e-08 | 1.209e-06 |
298 | PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 8 | 64 | 8.165e-08 | 1.275e-06 |
299 | REGULATION OF PROTEIN TARGETING | 15 | 307 | 8.196e-08 | 1.275e-06 |
300 | AGING | 14 | 264 | 8.249e-08 | 1.279e-06 |
301 | INFLAMMATORY RESPONSE | 18 | 454 | 9.518e-08 | 1.471e-06 |
302 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 26 | 917 | 1.058e-07 | 1.63e-06 |
303 | REGULATION OF HEMOPOIESIS | 15 | 314 | 1.099e-07 | 1.688e-06 |
304 | RESPONSE TO REACTIVE OXYGEN SPECIES | 12 | 191 | 1.154e-07 | 1.767e-06 |
305 | REGULATION OF CELL DIVISION | 14 | 272 | 1.192e-07 | 1.819e-06 |
306 | CELL ACTIVATION | 20 | 568 | 1.225e-07 | 1.863e-06 |
307 | PHOSPHATIDYLSERINE METABOLIC PROCESS | 6 | 28 | 1.278e-07 | 1.938e-06 |
308 | PEPTIDYL THREONINE MODIFICATION | 7 | 46 | 1.344e-07 | 2.031e-06 |
309 | REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 13 | 233 | 1.354e-07 | 2.038e-06 |
310 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 12 | 195 | 1.447e-07 | 2.172e-06 |
311 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 16 | 370 | 1.592e-07 | 2.381e-06 |
312 | POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT | 6 | 29 | 1.6e-07 | 2.387e-06 |
313 | MUSCLE CELL DIFFERENTIATION | 13 | 237 | 1.648e-07 | 2.451e-06 |
314 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 70 | 1.666e-07 | 2.469e-06 |
315 | POSITIVE REGULATION OF CELL DEVELOPMENT | 18 | 472 | 1.697e-07 | 2.498e-06 |
316 | REGULATION OF DNA REPLICATION | 11 | 161 | 1.697e-07 | 2.498e-06 |
317 | REGULATION OF LIPID BIOSYNTHETIC PROCESS | 10 | 128 | 1.796e-07 | 2.636e-06 |
318 | REGULATION OF LIPID KINASE ACTIVITY | 7 | 48 | 1.822e-07 | 2.667e-06 |
319 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 14 | 282 | 1.856e-07 | 2.707e-06 |
320 | NEGATIVE REGULATION OF CELL PROLIFERATION | 21 | 643 | 2.035e-07 | 2.958e-06 |
321 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 7 | 49 | 2.111e-07 | 3.059e-06 |
322 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 10 | 131 | 2.233e-07 | 3.226e-06 |
323 | REGULATION OF DEVELOPMENTAL GROWTH | 14 | 289 | 2.502e-07 | 3.604e-06 |
324 | NEGATIVE REGULATION OF CELL CYCLE | 17 | 433 | 2.533e-07 | 3.637e-06 |
325 | RESPONSE TO CARBOHYDRATE | 11 | 168 | 2.61e-07 | 3.736e-06 |
326 | SINGLE ORGANISM BEHAVIOR | 16 | 384 | 2.627e-07 | 3.75e-06 |
327 | RESPONSE TO CYTOKINE | 22 | 714 | 2.765e-07 | 3.935e-06 |
328 | REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 7 | 51 | 2.803e-07 | 3.977e-06 |
329 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 12 | 208 | 2.911e-07 | 4.117e-06 |
330 | REGULATION OF MEMBRANE POTENTIAL | 15 | 343 | 3.423e-07 | 4.827e-06 |
331 | PHOSPHATIDIC ACID METABOLIC PROCESS | 6 | 33 | 3.625e-07 | 5.096e-06 |
332 | CELLULAR RESPONSE TO HORMONE STIMULUS | 19 | 552 | 3.658e-07 | 5.126e-06 |
333 | REGULATION OF HOMEOSTATIC PROCESS | 17 | 447 | 3.956e-07 | 5.527e-06 |
334 | RESPONSE TO FLUID SHEAR STRESS | 6 | 34 | 4.37e-07 | 6.089e-06 |
335 | RESPONSE TO HYDROGEN PEROXIDE | 9 | 109 | 4.694e-07 | 6.52e-06 |
336 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 55 | 4.772e-07 | 6.608e-06 |
337 | NEURON PROJECTION MORPHOGENESIS | 16 | 402 | 4.845e-07 | 6.69e-06 |
338 | POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 19 | 4.957e-07 | 6.824e-06 |
339 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 23 | 801 | 4.99e-07 | 6.848e-06 |
340 | ALDITOL PHOSPHATE METABOLIC PROCESS | 6 | 35 | 5.237e-07 | 7.125e-06 |
341 | ACTIVATION OF JUN KINASE ACTIVITY | 6 | 35 | 5.237e-07 | 7.125e-06 |
342 | REGULATION OF CHEMOTAXIS | 11 | 180 | 5.212e-07 | 7.125e-06 |
343 | EMBRYONIC ORGAN DEVELOPMENT | 16 | 406 | 5.525e-07 | 7.495e-06 |
344 | REGULATION OF HEART CONTRACTION | 12 | 221 | 5.573e-07 | 7.538e-06 |
345 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 18 | 513 | 5.737e-07 | 7.738e-06 |
346 | NEGATIVE REGULATION OF GENE EXPRESSION | 33 | 1493 | 5.768e-07 | 7.757e-06 |
347 | REGULATION OF MYELOID CELL DIFFERENTIATION | 11 | 183 | 6.145e-07 | 8.24e-06 |
348 | NEUROMUSCULAR JUNCTION DEVELOPMENT | 6 | 36 | 6.239e-07 | 8.321e-06 |
349 | BEHAVIOR | 18 | 516 | 6.241e-07 | 8.321e-06 |
350 | PROTEIN REFOLDING | 5 | 20 | 6.563e-07 | 8.725e-06 |
351 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 9 | 114 | 6.877e-07 | 9.116e-06 |
352 | ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS | 8 | 85 | 7.603e-07 | 1.005e-05 |
353 | ORGANOPHOSPHATE METABOLIC PROCESS | 24 | 885 | 7.654e-07 | 1.009e-05 |
354 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 15 | 368 | 8.326e-07 | 1.094e-05 |
355 | MYELOID CELL DIFFERENTIATION | 11 | 189 | 8.461e-07 | 1.109e-05 |
356 | POSITIVE REGULATION OF ORGAN GROWTH | 6 | 38 | 8.716e-07 | 1.139e-05 |
357 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 7 | 60 | 8.756e-07 | 1.141e-05 |
358 | REGULATION OF MUSCLE CELL DIFFERENTIATION | 10 | 152 | 8.873e-07 | 1.153e-05 |
359 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 9 | 118 | 9.208e-07 | 1.193e-05 |
360 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 12 | 232 | 9.327e-07 | 1.205e-05 |
361 | REGULATION OF VASCULATURE DEVELOPMENT | 12 | 233 | 9.76e-07 | 1.258e-05 |
362 | REGULATION OF CATION CHANNEL ACTIVITY | 8 | 88 | 9.932e-07 | 1.277e-05 |
363 | CELL CYCLE ARREST | 10 | 154 | 1e-06 | 1.282e-05 |
364 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 39 | 1.023e-06 | 1.304e-05 |
365 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 6 | 39 | 1.023e-06 | 1.304e-05 |
366 | POSITIVE REGULATION OF CHEMOTAXIS | 9 | 120 | 1.061e-06 | 1.349e-05 |
367 | CELL CYCLE | 30 | 1316 | 1.093e-06 | 1.384e-05 |
368 | CONNECTIVE TISSUE DEVELOPMENT | 11 | 194 | 1.095e-06 | 1.384e-05 |
369 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 7 | 62 | 1.099e-06 | 1.386e-05 |
370 | CALCIUM MEDIATED SIGNALING | 8 | 90 | 1.18e-06 | 1.484e-05 |
371 | RESPIRATORY SYSTEM DEVELOPMENT | 11 | 197 | 1.273e-06 | 1.596e-05 |
372 | POSITIVE REGULATION OF CELL CYCLE | 14 | 332 | 1.317e-06 | 1.647e-05 |
373 | NEUROTROPHIN SIGNALING PATHWAY | 5 | 23 | 1.395e-06 | 1.74e-05 |
374 | SECOND MESSENGER MEDIATED SIGNALING | 10 | 160 | 1.418e-06 | 1.764e-05 |
375 | REGULATION OF ORGAN MORPHOGENESIS | 12 | 242 | 1.453e-06 | 1.803e-05 |
376 | ACTION POTENTIAL | 8 | 94 | 1.646e-06 | 2.031e-05 |
377 | REGULATION OF DNA BIOSYNTHETIC PROCESS | 8 | 94 | 1.646e-06 | 2.031e-05 |
378 | POSITIVE REGULATION OF HEMOPOIESIS | 10 | 163 | 1.679e-06 | 2.061e-05 |
379 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 10 | 163 | 1.679e-06 | 2.061e-05 |
380 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 18 | 554 | 1.721e-06 | 2.108e-05 |
381 | REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 8 | 95 | 1.784e-06 | 2.178e-05 |
382 | MYELOID LEUKOCYTE DIFFERENTIATION | 8 | 96 | 1.932e-06 | 2.353e-05 |
383 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 9 | 129 | 1.945e-06 | 2.359e-05 |
384 | REGULATION OF CYTOSKELETON ORGANIZATION | 17 | 502 | 1.947e-06 | 2.359e-05 |
385 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 21 | 740 | 1.967e-06 | 2.371e-05 |
386 | REGULATION OF BLOOD CIRCULATION | 13 | 295 | 1.963e-06 | 2.371e-05 |
387 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 17 | 505 | 2.11e-06 | 2.537e-05 |
388 | COGNITION | 12 | 251 | 2.127e-06 | 2.551e-05 |
389 | REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 25 | 2.171e-06 | 2.584e-05 |
390 | HISTONE PHOSPHORYLATION | 5 | 25 | 2.171e-06 | 2.584e-05 |
391 | POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 5 | 25 | 2.171e-06 | 2.584e-05 |
392 | REGULATION OF PROTEIN BINDING | 10 | 168 | 2.206e-06 | 2.619e-05 |
393 | REGULATION OF SYSTEM PROCESS | 17 | 507 | 2.225e-06 | 2.634e-05 |
394 | EPIDERMIS DEVELOPMENT | 12 | 253 | 2.309e-06 | 2.727e-05 |
395 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 32 | 1517 | 2.409e-06 | 2.838e-05 |
396 | LUNG MORPHOGENESIS | 6 | 45 | 2.445e-06 | 2.873e-05 |
397 | REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 4 | 12 | 2.594e-06 | 3.041e-05 |
398 | REGULATION OF P38MAPK CASCADE | 5 | 26 | 2.669e-06 | 3.12e-05 |
399 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 15 | 406 | 2.808e-06 | 3.275e-05 |
400 | NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 8 | 102 | 3.056e-06 | 3.555e-05 |
401 | FOREBRAIN DEVELOPMENT | 14 | 357 | 3.075e-06 | 3.568e-05 |
402 | POSITIVE REGULATION OF HEART GROWTH | 5 | 27 | 3.253e-06 | 3.756e-05 |
403 | POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 27 | 3.253e-06 | 3.756e-05 |
404 | REGULATION OF MUSCLE TISSUE DEVELOPMENT | 8 | 103 | 3.289e-06 | 3.779e-05 |
405 | REGULATION OF MUSCLE ORGAN DEVELOPMENT | 8 | 103 | 3.289e-06 | 3.779e-05 |
406 | POSITIVE REGULATION OF PROTEIN IMPORT | 8 | 104 | 3.537e-06 | 4.054e-05 |
407 | REGULATION OF MYOBLAST DIFFERENTIATION | 6 | 48 | 3.605e-06 | 4.122e-05 |
408 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 13 | 312 | 3.632e-06 | 4.142e-05 |
409 | CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 7 | 74 | 3.684e-06 | 4.191e-05 |
410 | REGULATION OF OSSIFICATION | 10 | 178 | 3.708e-06 | 4.208e-05 |
411 | INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 4 | 13 | 3.722e-06 | 4.214e-05 |
412 | REGULATION OF SYNAPTIC PLASTICITY | 9 | 140 | 3.83e-06 | 4.326e-05 |
413 | POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 5 | 28 | 3.932e-06 | 4.43e-05 |
414 | REGULATION OF PROTEOLYSIS | 20 | 711 | 4.011e-06 | 4.508e-05 |
415 | POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 8 | 106 | 4.081e-06 | 4.576e-05 |
416 | PLATELET ACTIVATION | 9 | 142 | 4.304e-06 | 4.814e-05 |
417 | REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 6 | 50 | 4.602e-06 | 5.135e-05 |
418 | REGULATION OF IMMUNE EFFECTOR PROCESS | 15 | 424 | 4.754e-06 | 5.292e-05 |
419 | NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 14 | 372 | 4.94e-06 | 5.486e-05 |
420 | POSITIVE REGULATION OF METANEPHROS DEVELOPMENT | 4 | 14 | 5.176e-06 | 5.707e-05 |
421 | POSITIVE REGULATION OF P38MAPK CASCADE | 4 | 14 | 5.176e-06 | 5.707e-05 |
422 | RESPONSE TO LAMINAR FLUID SHEAR STRESS | 4 | 14 | 5.176e-06 | 5.707e-05 |
423 | T CELL RECEPTOR SIGNALING PATHWAY | 9 | 146 | 5.404e-06 | 5.944e-05 |
424 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 18 | 602 | 5.478e-06 | 6.011e-05 |
425 | POSITIVE REGULATION OF CELL ADHESION | 14 | 376 | 5.583e-06 | 6.112e-05 |
426 | CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 5 | 30 | 5.622e-06 | 6.14e-05 |
427 | ERBB SIGNALING PATHWAY | 7 | 79 | 5.721e-06 | 6.234e-05 |
428 | EYE DEVELOPMENT | 13 | 326 | 5.849e-06 | 6.359e-05 |
429 | RESPONSE TO TEMPERATURE STIMULUS | 9 | 148 | 6.039e-06 | 6.55e-05 |
430 | REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 6 | 53 | 6.507e-06 | 7.041e-05 |
431 | OVULATION CYCLE | 8 | 113 | 6.576e-06 | 7.1e-05 |
432 | POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 7 | 81 | 6.763e-06 | 7.285e-05 |
433 | POSITIVE REGULATION OF ION TRANSPORT | 11 | 236 | 7.273e-06 | 7.815e-05 |
434 | RESPONSE TO METAL ION | 13 | 333 | 7.352e-06 | 7.883e-05 |
435 | REPRODUCTION | 28 | 1297 | 7.389e-06 | 7.903e-05 |
436 | RESPONSE TO STEROID HORMONE | 16 | 497 | 7.491e-06 | 7.976e-05 |
437 | RESPONSE TO INTERLEUKIN 1 | 8 | 115 | 7.49e-06 | 7.976e-05 |
438 | CELL CYCLE PROCESS | 25 | 1081 | 7.556e-06 | 8.027e-05 |
439 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 5 | 32 | 7.833e-06 | 8.284e-05 |
440 | NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 5 | 32 | 7.833e-06 | 8.284e-05 |
441 | CELL CYCLE CHECKPOINT | 10 | 194 | 7.953e-06 | 8.392e-05 |
442 | REGULATION OF KIDNEY DEVELOPMENT | 6 | 55 | 8.099e-06 | 8.507e-05 |
443 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 6 | 55 | 8.099e-06 | 8.507e-05 |
444 | DEFENSE RESPONSE | 27 | 1231 | 8.259e-06 | 8.656e-05 |
445 | POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 9 | 154 | 8.341e-06 | 8.722e-05 |
446 | CELLULAR MACROMOLECULE LOCALIZATION | 27 | 1234 | 8.632e-06 | 9.005e-05 |
447 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 20 | 750 | 8.834e-06 | 9.195e-05 |
448 | REGULATION OF PEPTIDASE ACTIVITY | 14 | 392 | 8.961e-06 | 9.307e-05 |
449 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 56 | 9.006e-06 | 9.333e-05 |
450 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 9 | 156 | 9.26e-06 | 9.574e-05 |
451 | TOLL LIKE RECEPTOR SIGNALING PATHWAY | 7 | 85 | 9.324e-06 | 9.62e-05 |
452 | ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 15 | 450 | 9.688e-06 | 9.973e-05 |
453 | REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 6 | 57 | 9.993e-06 | 0.0001026 |
454 | NEGATIVE REGULATION OF CELL ACTIVATION | 9 | 158 | 1.026e-05 | 0.0001052 |
455 | FOREBRAIN NEURON DEVELOPMENT | 5 | 34 | 1.067e-05 | 0.0001087 |
456 | ORGAN FORMATION | 5 | 34 | 1.067e-05 | 0.0001087 |
457 | REGULATION OF MESENCHYMAL CELL PROLIFERATION | 5 | 34 | 1.067e-05 | 0.0001087 |
458 | SKELETAL SYSTEM MORPHOGENESIS | 10 | 201 | 1.085e-05 | 0.0001102 |
459 | TISSUE REMODELING | 7 | 87 | 1.088e-05 | 0.0001103 |
460 | REGULATION OF PROTEIN KINASE B SIGNALING | 8 | 121 | 1.09e-05 | 0.0001103 |
461 | CELLULAR RESPONSE TO INTERLEUKIN 1 | 7 | 88 | 1.173e-05 | 0.0001177 |
462 | OVULATION CYCLE PROCESS | 7 | 88 | 1.173e-05 | 0.0001177 |
463 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 88 | 1.173e-05 | 0.0001177 |
464 | REGULATION OF STEM CELL PROLIFERATION | 7 | 88 | 1.173e-05 | 0.0001177 |
465 | REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 4 | 17 | 1.206e-05 | 0.0001204 |
466 | REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 4 | 17 | 1.206e-05 | 0.0001204 |
467 | BONE REMODELING | 5 | 35 | 1.236e-05 | 0.0001232 |
468 | RESPONSE TO PEPTIDE | 14 | 404 | 1.258e-05 | 0.000125 |
469 | RESPONSE TO HEAT | 7 | 89 | 1.264e-05 | 0.000125 |
470 | UROGENITAL SYSTEM DEVELOPMENT | 12 | 299 | 1.265e-05 | 0.000125 |
471 | EPITHELIAL CELL PROLIFERATION | 7 | 89 | 1.264e-05 | 0.000125 |
472 | HOMEOSTATIC PROCESS | 28 | 1337 | 1.297e-05 | 0.0001278 |
473 | REGULATION OF VESICLE MEDIATED TRANSPORT | 15 | 462 | 1.322e-05 | 0.00013 |
474 | CYTOSKELETON ORGANIZATION | 21 | 838 | 1.33e-05 | 0.0001306 |
475 | CHONDROCYTE DIFFERENTIATION | 6 | 60 | 1.349e-05 | 0.0001322 |
476 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 12 | 303 | 1.445e-05 | 0.0001412 |
477 | RESPONSE TO UV | 8 | 126 | 1.467e-05 | 0.0001431 |
478 | REGULATION OF INTERLEUKIN 8 PRODUCTION | 6 | 61 | 1.486e-05 | 0.0001443 |
479 | GROWTH | 14 | 410 | 1.483e-05 | 0.0001443 |
480 | CELLULAR LIPID METABOLIC PROCESS | 22 | 913 | 1.499e-05 | 0.0001453 |
481 | INOSITOL PHOSPHATE MEDIATED SIGNALING | 4 | 18 | 1.54e-05 | 0.0001489 |
482 | POSITIVE REGULATION OF BINDING | 8 | 127 | 1.554e-05 | 0.00015 |
483 | REGULATION OF PEPTIDE TRANSPORT | 11 | 256 | 1.561e-05 | 0.0001504 |
484 | MUSCLE CELL DEVELOPMENT | 8 | 128 | 1.645e-05 | 0.0001582 |
485 | POSITIVE REGULATION OF PROTEIN SECRETION | 10 | 211 | 1.655e-05 | 0.0001584 |
486 | SKIN DEVELOPMENT | 10 | 211 | 1.655e-05 | 0.0001584 |
487 | REGULATION OF REPRODUCTIVE PROCESS | 8 | 129 | 1.741e-05 | 0.0001664 |
488 | AMMONIUM ION METABOLIC PROCESS | 9 | 169 | 1.76e-05 | 0.0001678 |
489 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 10 | 213 | 1.795e-05 | 0.0001708 |
490 | RESPONSE TO OXYGEN LEVELS | 12 | 311 | 1.871e-05 | 0.0001773 |
491 | POSITIVE REGULATION OF CELL ACTIVATION | 12 | 311 | 1.871e-05 | 0.0001773 |
492 | RESPONSE TO MUSCLE STRETCH | 4 | 19 | 1.937e-05 | 0.0001828 |
493 | NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 4 | 19 | 1.937e-05 | 0.0001828 |
494 | POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION | 8 | 131 | 1.947e-05 | 0.000183 |
495 | AMINE METABOLIC PROCESS | 8 | 131 | 1.947e-05 | 0.000183 |
496 | ERBB2 SIGNALING PATHWAY | 5 | 39 | 2.132e-05 | 2e-04 |
497 | CALCIUM ION IMPORT | 6 | 65 | 2.148e-05 | 0.0002011 |
498 | SYNAPTIC SIGNALING | 14 | 424 | 2.152e-05 | 0.0002011 |
499 | RESPONSE TO ESTROGEN | 10 | 218 | 2.192e-05 | 0.0002044 |
500 | POSITIVE REGULATION OF SECRETION | 13 | 370 | 2.244e-05 | 0.0002088 |
501 | ACID SECRETION | 6 | 66 | 2.346e-05 | 0.0002174 |
502 | POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 6 | 66 | 2.346e-05 | 0.0002174 |
503 | NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 98 | 2.377e-05 | 0.0002199 |
504 | RESPONSE TO ACID CHEMICAL | 12 | 319 | 2.403e-05 | 0.0002216 |
505 | MYELOID DENDRITIC CELL DIFFERENTIATION | 4 | 20 | 2.405e-05 | 0.0002216 |
506 | CELL GROWTH | 8 | 135 | 2.421e-05 | 0.0002226 |
507 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 6 | 67 | 2.558e-05 | 0.0002343 |
508 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 6 | 67 | 2.558e-05 | 0.0002343 |
509 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 7 | 100 | 2.711e-05 | 0.0002478 |
510 | POSITIVE REGULATION OF KIDNEY DEVELOPMENT | 5 | 41 | 2.736e-05 | 0.0002496 |
511 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 6 | 68 | 2.785e-05 | 0.0002536 |
512 | PLACENTA DEVELOPMENT | 8 | 138 | 2.837e-05 | 0.0002578 |
513 | NEGATIVE REGULATION OF ORGAN GROWTH | 4 | 21 | 2.951e-05 | 0.0002676 |
514 | POSITIVE REGULATION OF AXONOGENESIS | 6 | 69 | 3.029e-05 | 0.0002742 |
515 | REGULATION OF CELL PROJECTION ORGANIZATION | 16 | 558 | 3.1e-05 | 0.0002801 |
516 | PROTEIN LOCALIZATION | 33 | 1805 | 3.257e-05 | 0.0002937 |
517 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 6 | 70 | 3.289e-05 | 0.0002954 |
518 | REGULATION OF MEMBRANE PERMEABILITY | 6 | 70 | 3.289e-05 | 0.0002954 |
519 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 9 | 184 | 3.448e-05 | 0.0003091 |
520 | REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 43 | 3.466e-05 | 0.0003101 |
521 | SKIN EPIDERMIS DEVELOPMENT | 6 | 71 | 3.567e-05 | 0.0003186 |
522 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 4 | 22 | 3.582e-05 | 0.0003187 |
523 | SOMATIC STEM CELL DIVISION | 4 | 22 | 3.582e-05 | 0.0003187 |
524 | CEREBRAL CORTEX DEVELOPMENT | 7 | 105 | 3.717e-05 | 0.00033 |
525 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 10 | 232 | 3.728e-05 | 0.0003304 |
526 | REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 8 | 144 | 3.849e-05 | 0.0003405 |
527 | RESPONSE TO TUMOR NECROSIS FACTOR | 10 | 233 | 3.867e-05 | 0.0003414 |
528 | REGULATION OF FAT CELL DIFFERENTIATION | 7 | 106 | 3.951e-05 | 0.0003482 |
529 | CELL PART MORPHOGENESIS | 17 | 633 | 3.964e-05 | 0.0003487 |
530 | DNA INTEGRITY CHECKPOINT | 8 | 146 | 4.247e-05 | 0.0003728 |
531 | NEGATIVE REGULATION OF GROWTH | 10 | 236 | 4.308e-05 | 0.0003768 |
532 | REGULATION OF METANEPHROS DEVELOPMENT | 4 | 23 | 4.307e-05 | 0.0003768 |
533 | CARTILAGE DEVELOPMENT | 8 | 147 | 4.458e-05 | 0.0003885 |
534 | REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 7 | 108 | 4.455e-05 | 0.0003885 |
535 | DIGESTIVE SYSTEM DEVELOPMENT | 8 | 148 | 4.679e-05 | 0.0004069 |
536 | PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 7 | 109 | 4.726e-05 | 0.0004103 |
537 | EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 5 | 46 | 4.832e-05 | 0.0004187 |
538 | NEGATIVE REGULATION OF TRANSPORT | 14 | 458 | 4.988e-05 | 0.0004314 |
539 | METAL ION TRANSPORT | 16 | 582 | 5.123e-05 | 0.0004422 |
540 | PROTEIN LOCALIZATION TO CELL PERIPHERY | 8 | 151 | 5.395e-05 | 0.0004648 |
541 | POSITIVE REGULATION OF CELL CELL ADHESION | 10 | 243 | 5.509e-05 | 0.0004738 |
542 | INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 152 | 5.653e-05 | 0.0004853 |
543 | SECRETION | 16 | 588 | 5.782e-05 | 0.0004955 |
544 | PALLIUM DEVELOPMENT | 8 | 153 | 5.921e-05 | 0.0005064 |
545 | EPITHELIAL CELL APOPTOTIC PROCESS | 4 | 25 | 6.069e-05 | 0.0005182 |
546 | REPRODUCTIVE SYSTEM DEVELOPMENT | 13 | 408 | 6.135e-05 | 0.0005229 |
547 | REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 7 | 114 | 6.293e-05 | 0.0005334 |
548 | REGULATION OF EMBRYONIC DEVELOPMENT | 7 | 114 | 6.293e-05 | 0.0005334 |
549 | REGULATION OF MITOTIC CELL CYCLE | 14 | 468 | 6.287e-05 | 0.0005334 |
550 | SYSTEM PROCESS | 32 | 1785 | 6.392e-05 | 0.0005408 |
551 | BONE MORPHOGENESIS | 6 | 79 | 6.537e-05 | 0.000552 |
552 | NEPHRON DEVELOPMENT | 7 | 115 | 6.653e-05 | 0.0005598 |
553 | RESPONSE TO CALCIUM ION | 7 | 115 | 6.653e-05 | 0.0005598 |
554 | REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 8 | 156 | 6.79e-05 | 0.0005692 |
555 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 8 | 156 | 6.79e-05 | 0.0005692 |
556 | LIPID METABOLIC PROCESS | 24 | 1158 | 6.81e-05 | 0.0005699 |
557 | MYELOID DENDRITIC CELL ACTIVATION | 4 | 26 | 7.124e-05 | 0.0005951 |
558 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 5 | 50 | 7.262e-05 | 0.0006013 |
559 | LYMPHOCYTE HOMEOSTASIS | 5 | 50 | 7.262e-05 | 0.0006013 |
560 | FACE DEVELOPMENT | 5 | 50 | 7.262e-05 | 0.0006013 |
561 | OSSIFICATION | 10 | 251 | 7.22e-05 | 0.0006013 |
562 | POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 5 | 50 | 7.262e-05 | 0.0006013 |
563 | POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING | 6 | 81 | 7.524e-05 | 0.0006218 |
564 | LIPID BIOSYNTHETIC PROCESS | 15 | 539 | 7.731e-05 | 0.0006378 |
565 | NEURON PROJECTION GUIDANCE | 9 | 205 | 7.969e-05 | 0.0006563 |
566 | REGULATION OF INTERLEUKIN 12 PRODUCTION | 5 | 51 | 7.996e-05 | 0.0006573 |
567 | HAIR CYCLE | 6 | 83 | 8.626e-05 | 0.0007041 |
568 | EMBRYONIC PLACENTA DEVELOPMENT | 6 | 83 | 8.626e-05 | 0.0007041 |
569 | NIK NF KAPPAB SIGNALING | 6 | 83 | 8.626e-05 | 0.0007041 |
570 | MOLTING CYCLE | 6 | 83 | 8.626e-05 | 0.0007041 |
571 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 7 | 120 | 8.71e-05 | 0.0007098 |
572 | CELL CHEMOTAXIS | 8 | 162 | 8.848e-05 | 0.0007185 |
573 | POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 8 | 162 | 8.848e-05 | 0.0007185 |
574 | IN UTERO EMBRYONIC DEVELOPMENT | 11 | 311 | 9.156e-05 | 0.0007409 |
575 | HEMOSTASIS | 11 | 311 | 9.156e-05 | 0.0007409 |
576 | POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 6 | 84 | 9.223e-05 | 0.0007411 |
577 | NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 6 | 84 | 9.223e-05 | 0.0007411 |
578 | REGULATION OF PEPTIDE SECRETION | 9 | 209 | 9.238e-05 | 0.0007411 |
579 | NEGATIVE REGULATION OF IMMUNE RESPONSE | 7 | 121 | 9.178e-05 | 0.0007411 |
580 | POSITIVE REGULATION OF OSSIFICATION | 6 | 84 | 9.223e-05 | 0.0007411 |
581 | NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 4 | 28 | 9.626e-05 | 0.0007674 |
582 | NECROTIC CELL DEATH | 4 | 28 | 9.626e-05 | 0.0007674 |
583 | REGULATION OF FIBROBLAST MIGRATION | 4 | 28 | 9.626e-05 | 0.0007674 |
584 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 53 | 9.632e-05 | 0.0007674 |
585 | POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 3 | 11 | 0.0001015 | 0.0008042 |
586 | REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 3 | 11 | 0.0001015 | 0.0008042 |
587 | POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 3 | 11 | 0.0001015 | 0.0008042 |
588 | REGULATION OF ADAPTIVE IMMUNE RESPONSE | 7 | 123 | 0.0001018 | 0.0008052 |
589 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 17 | 684 | 0.0001025 | 0.0008096 |
590 | REGULATION OF NEURON DIFFERENTIATION | 15 | 554 | 0.0001048 | 0.0008265 |
591 | NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 4 | 29 | 0.0001109 | 0.0008673 |
592 | REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 4 | 29 | 0.0001109 | 0.0008673 |
593 | POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 4 | 29 | 0.0001109 | 0.0008673 |
594 | REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 4 | 29 | 0.0001109 | 0.0008673 |
595 | STEM CELL DIVISION | 4 | 29 | 0.0001109 | 0.0008673 |
596 | SINGLE ORGANISM CELLULAR LOCALIZATION | 20 | 898 | 0.0001111 | 0.0008676 |
597 | KIDNEY EPITHELIUM DEVELOPMENT | 7 | 125 | 0.0001126 | 0.0008776 |
598 | REGULATION OF PROTEIN COMPLEX ASSEMBLY | 12 | 375 | 0.0001136 | 0.0008836 |
599 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 5 | 55 | 0.0001151 | 0.0008943 |
600 | REGULATION OF WOUND HEALING | 7 | 126 | 0.0001184 | 0.0009178 |
601 | POSITIVE REGULATION OF HOMEOSTATIC PROCESS | 9 | 216 | 0.0001187 | 0.0009188 |
602 | SMAD PROTEIN SIGNAL TRANSDUCTION | 5 | 56 | 0.0001255 | 0.0009703 |
603 | REGULATION OF MITOCHONDRION ORGANIZATION | 9 | 218 | 0.0001273 | 0.0009803 |
604 | REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 4 | 30 | 0.0001271 | 0.0009803 |
605 | REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 3 | 12 | 0.0001344 | 0.001032 |
606 | TRACHEA MORPHOGENESIS | 3 | 12 | 0.0001344 | 0.001032 |
607 | MESONEPHROS DEVELOPMENT | 6 | 90 | 0.0001353 | 0.001037 |
608 | CELLULAR CHEMICAL HOMEOSTASIS | 15 | 570 | 0.0001432 | 0.001096 |
609 | REGULATION OF PLATELET ACTIVATION | 4 | 31 | 0.0001449 | 0.001107 |
610 | CELLULAR RESPONSE TO PEPTIDE | 10 | 274 | 0.0001485 | 0.001133 |
611 | GLIOGENESIS | 8 | 175 | 0.0001511 | 0.001143 |
612 | LEARNING | 7 | 131 | 0.0001509 | 0.001143 |
613 | HOMEOSTASIS OF NUMBER OF CELLS | 8 | 175 | 0.0001511 | 0.001143 |
614 | NEGATIVE REGULATION OF BINDING | 7 | 131 | 0.0001509 | 0.001143 |
615 | NEGATIVE REGULATION OF CELL ADHESION | 9 | 223 | 0.000151 | 0.001143 |
616 | MUSCLE TISSUE DEVELOPMENT | 10 | 275 | 0.000153 | 0.001154 |
617 | MITOCHONDRIAL MEMBRANE ORGANIZATION | 6 | 92 | 0.0001528 | 0.001154 |
618 | RESPONSE TO CORTICOSTEROID | 8 | 176 | 0.0001572 | 0.001183 |
619 | POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 5 | 59 | 0.0001611 | 0.001211 |
620 | REGULATION OF ACTIN CYTOSKELETON REORGANIZATION | 4 | 32 | 0.0001645 | 0.001235 |
621 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 7 | 133 | 0.0001657 | 0.001242 |
622 | DEVELOPMENTAL GROWTH | 11 | 333 | 0.0001668 | 0.001248 |
623 | NEURONAL STEM CELL DIVISION | 3 | 13 | 0.0001736 | 0.00128 |
624 | REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 3 | 13 | 0.0001736 | 0.00128 |
625 | REGULATION OF MEMBRANE LIPID METABOLIC PROCESS | 3 | 13 | 0.0001736 | 0.00128 |
626 | PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 3 | 13 | 0.0001736 | 0.00128 |
627 | REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 3 | 13 | 0.0001736 | 0.00128 |
628 | EYELID DEVELOPMENT IN CAMERA TYPE EYE | 3 | 13 | 0.0001736 | 0.00128 |
629 | HEPATOCYTE APOPTOTIC PROCESS | 3 | 13 | 0.0001736 | 0.00128 |
630 | REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS | 6 | 94 | 0.000172 | 0.00128 |
631 | NEUROBLAST DIVISION | 3 | 13 | 0.0001736 | 0.00128 |
632 | LEUKOCYTE HOMEOSTASIS | 5 | 60 | 0.0001745 | 0.001285 |
633 | TELENCEPHALON DEVELOPMENT | 9 | 228 | 0.0001783 | 0.00131 |
634 | ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 6 | 95 | 0.0001823 | 0.001338 |
635 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 9 | 229 | 0.0001842 | 0.00135 |
636 | DENDRITIC CELL DIFFERENTIATION | 4 | 33 | 0.000186 | 0.001352 |
637 | CELLULAR SENESCENCE | 4 | 33 | 0.000186 | 0.001352 |
638 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 4 | 33 | 0.000186 | 0.001352 |
639 | CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 4 | 33 | 0.000186 | 0.001352 |
640 | G2 DNA DAMAGE CHECKPOINT | 4 | 33 | 0.000186 | 0.001352 |
641 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 5 | 61 | 0.0001888 | 0.001368 |
642 | CELLULAR RESPONSE TO DNA DAMAGE STIMULUS | 17 | 720 | 0.0001888 | 0.001368 |
643 | GLIAL CELL DIFFERENTIATION | 7 | 136 | 0.0001903 | 0.001377 |
644 | NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 12 | 397 | 0.0001928 | 0.001393 |
645 | NEGATIVE REGULATION OF CELL CELL ADHESION | 7 | 138 | 0.0002082 | 0.001502 |
646 | PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 4 | 34 | 0.0002093 | 0.001505 |
647 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 4 | 34 | 0.0002093 | 0.001505 |
648 | MYELOID LEUKOCYTE ACTIVATION | 6 | 98 | 0.0002161 | 0.001549 |
649 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 6 | 98 | 0.0002161 | 0.001549 |
650 | REGULATION OF RESPIRATORY BURST | 3 | 14 | 0.0002195 | 0.00156 |
651 | ARACHIDONIC ACID SECRETION | 3 | 14 | 0.0002195 | 0.00156 |
652 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 3 | 14 | 0.0002195 | 0.00156 |
653 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 3 | 14 | 0.0002195 | 0.00156 |
654 | ARACHIDONATE TRANSPORT | 3 | 14 | 0.0002195 | 0.00156 |
655 | REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 3 | 14 | 0.0002195 | 0.00156 |
656 | RESPONSE TO OSMOTIC STRESS | 5 | 63 | 0.0002199 | 0.00156 |
657 | CELL JUNCTION ORGANIZATION | 8 | 185 | 0.000221 | 0.001565 |
658 | CHEMICAL HOMEOSTASIS | 19 | 874 | 0.0002263 | 0.001601 |
659 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 12 | 408 | 0.0002477 | 0.001749 |
660 | LEUKOCYTE DIFFERENTIATION | 10 | 292 | 0.000248 | 0.001749 |
661 | ESTABLISHMENT OF PROTEIN LOCALIZATION | 26 | 1423 | 0.0002542 | 0.001789 |
662 | REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 6 | 101 | 0.0002546 | 0.00179 |
663 | NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 7 | 143 | 0.000259 | 0.001818 |
664 | CELLULAR RESPONSE TO HEAT | 4 | 36 | 0.0002623 | 0.00183 |
665 | POSITIVE REGULATION OF PROTEIN ACETYLATION | 4 | 36 | 0.0002623 | 0.00183 |
666 | POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 4 | 36 | 0.0002623 | 0.00183 |
667 | POSITIVE CHEMOTAXIS | 4 | 36 | 0.0002623 | 0.00183 |
668 | RESPONSE TO TOXIC SUBSTANCE | 9 | 241 | 0.0002691 | 0.001875 |
669 | NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS | 3 | 15 | 0.0002727 | 0.001885 |
670 | ESTABLISHMENT OF LOCALIZATION IN CELL | 29 | 1676 | 0.0002712 | 0.001885 |
671 | POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 3 | 15 | 0.0002727 | 0.001885 |
672 | REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 3 | 15 | 0.0002727 | 0.001885 |
673 | NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 3 | 15 | 0.0002727 | 0.001885 |
674 | FOREBRAIN GENERATION OF NEURONS | 5 | 66 | 0.0002738 | 0.001891 |
675 | SYNAPSE ORGANIZATION | 7 | 145 | 0.0002819 | 0.001943 |
676 | NUCLEAR TRANSPORT | 11 | 355 | 0.0002891 | 0.00199 |
677 | CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 4 | 37 | 0.0002921 | 0.002005 |
678 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 4 | 37 | 0.0002921 | 0.002005 |
679 | RESPONSE TO ESTRADIOL | 7 | 146 | 0.000294 | 0.002014 |
680 | RESPONSE TO CAMP | 6 | 104 | 0.0002984 | 0.002039 |
681 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 6 | 104 | 0.0002984 | 0.002039 |
682 | ORGAN GROWTH | 5 | 68 | 0.000315 | 0.002149 |
683 | EAR DEVELOPMENT | 8 | 195 | 0.0003155 | 0.002149 |
684 | POSITIVE REGULATION OF CELL GROWTH | 7 | 148 | 0.0003193 | 0.002172 |
685 | MEMBRANE ORGANIZATION | 19 | 899 | 0.0003222 | 0.002189 |
686 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 4 | 38 | 0.0003243 | 0.0022 |
687 | REGULATION OF INCLUSION BODY ASSEMBLY | 3 | 16 | 0.0003335 | 0.002255 |
688 | BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 3 | 16 | 0.0003335 | 0.002255 |
689 | POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 5 | 69 | 0.0003372 | 0.002277 |
690 | POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY | 8 | 197 | 0.0003378 | 0.002278 |
691 | RESPONSE TO ALCOHOL | 11 | 362 | 0.0003412 | 0.002297 |
692 | PLATELET DEGRANULATION | 6 | 107 | 0.0003479 | 0.002339 |
693 | NEGATIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 4 | 39 | 0.0003589 | 0.002406 |
694 | WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY | 4 | 39 | 0.0003589 | 0.002406 |
695 | NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 8 | 200 | 0.0003738 | 0.002503 |
696 | REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 6 | 109 | 0.0003842 | 0.002569 |
697 | ENDODERM DEVELOPMENT | 5 | 71 | 0.0003853 | 0.002572 |
698 | REGULATION OF MEIOTIC CELL CYCLE | 4 | 40 | 0.0003961 | 0.002637 |
699 | NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 4 | 40 | 0.0003961 | 0.002637 |
700 | MULTICELLULAR ORGANISM REPRODUCTION | 17 | 768 | 0.0003988 | 0.002651 |
701 | BRANCH ELONGATION OF AN EPITHELIUM | 3 | 17 | 0.0004023 | 0.002659 |
702 | NEGATIVE REGULATION OF PLATELET ACTIVATION | 3 | 17 | 0.0004023 | 0.002659 |
703 | REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 3 | 17 | 0.0004023 | 0.002659 |
704 | POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 3 | 17 | 0.0004023 | 0.002659 |
705 | FORMATION OF PRIMARY GERM LAYER | 6 | 110 | 0.0004035 | 0.002659 |
706 | NEURON MIGRATION | 6 | 110 | 0.0004035 | 0.002659 |
707 | EPITHELIAL CELL DIFFERENTIATION | 13 | 495 | 0.000408 | 0.002685 |
708 | PLASMA MEMBRANE ORGANIZATION | 8 | 203 | 0.0004128 | 0.002713 |
709 | GASTRULATION | 7 | 155 | 0.0004222 | 0.002771 |
710 | NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE | 4 | 41 | 0.000436 | 0.002849 |
711 | NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 4 | 41 | 0.000436 | 0.002849 |
712 | LUNG ALVEOLUS DEVELOPMENT | 4 | 41 | 0.000436 | 0.002849 |
713 | POSITIVE REGULATION OF PROTEIN BINDING | 5 | 73 | 0.0004383 | 0.00286 |
714 | CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 7 | 156 | 0.0004389 | 0.00286 |
715 | RESPONSE TO AMINO ACID | 6 | 112 | 0.0004443 | 0.002884 |
716 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 6 | 112 | 0.0004443 | 0.002884 |
717 | ZYMOGEN ACTIVATION | 6 | 112 | 0.0004443 | 0.002884 |
718 | REGULATION OF LEUKOCYTE PROLIFERATION | 8 | 206 | 0.0004551 | 0.002947 |
719 | LEUKOCYTE MIGRATION | 9 | 259 | 0.0004554 | 0.002947 |
720 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 74 | 0.0004668 | 0.003016 |
721 | PROTEIN LOCALIZATION TO MEMBRANE | 11 | 376 | 0.0004693 | 0.003029 |
722 | REGULATION OF HETEROTYPIC CELL CELL ADHESION | 3 | 18 | 0.0004797 | 0.003092 |
723 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 9 | 262 | 0.0004949 | 0.003181 |
724 | REGULATION OF HORMONE SECRETION | 9 | 262 | 0.0004949 | 0.003181 |
725 | RESPONSE TO EXTRACELLULAR STIMULUS | 12 | 441 | 0.0004982 | 0.003197 |
726 | REGULATION OF BODY FLUID LEVELS | 13 | 506 | 0.0005017 | 0.003216 |
727 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 6 | 115 | 0.0005115 | 0.003274 |
728 | REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 4 | 43 | 0.0005241 | 0.003345 |
729 | CEREBRAL CORTEX CELL MIGRATION | 4 | 43 | 0.0005241 | 0.003345 |
730 | REGULATION OF CELLULAR RESPONSE TO HEAT | 5 | 76 | 0.0005279 | 0.003365 |
731 | FEMALE SEX DIFFERENTIATION | 6 | 116 | 0.0005356 | 0.003409 |
732 | CELLULAR RESPONSE TO FLUID SHEAR STRESS | 3 | 19 | 0.000566 | 0.003579 |
733 | REGULATION OF ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY | 3 | 19 | 0.000566 | 0.003579 |
734 | KIDNEY VASCULATURE DEVELOPMENT | 3 | 19 | 0.000566 | 0.003579 |
735 | RENAL SYSTEM VASCULATURE DEVELOPMENT | 3 | 19 | 0.000566 | 0.003579 |
736 | POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 3 | 19 | 0.000566 | 0.003579 |
737 | MULTI MULTICELLULAR ORGANISM PROCESS | 8 | 213 | 0.0005674 | 0.003583 |
738 | INORGANIC ION TRANSMEMBRANE TRANSPORT | 14 | 583 | 0.0005974 | 0.003766 |
739 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 16 | 724 | 0.000603 | 0.003797 |
740 | POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 4 | 45 | 0.0006243 | 0.003925 |
741 | REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 5 | 79 | 0.0006306 | 0.00396 |
742 | MULTICELLULAR ORGANISMAL HOMEOSTASIS | 9 | 272 | 0.0006474 | 0.00406 |
743 | REGULATION OF CELL GROWTH | 11 | 391 | 0.0006491 | 0.004065 |
744 | POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 3 | 20 | 0.0006617 | 0.0041 |
745 | EMBRYONIC HEMOPOIESIS | 3 | 20 | 0.0006617 | 0.0041 |
746 | REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 3 | 20 | 0.0006617 | 0.0041 |
747 | ICOSANOID TRANSPORT | 3 | 20 | 0.0006617 | 0.0041 |
748 | SKELETAL SYSTEM DEVELOPMENT | 12 | 455 | 0.000656 | 0.0041 |
749 | POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 7 | 167 | 0.000659 | 0.0041 |
750 | FATTY ACID DERIVATIVE TRANSPORT | 3 | 20 | 0.0006617 | 0.0041 |
751 | TRACHEA DEVELOPMENT | 3 | 20 | 0.0006617 | 0.0041 |
752 | REGULATION OF AXONOGENESIS | 7 | 168 | 0.0006827 | 0.004218 |
753 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 9 | 274 | 0.0006821 | 0.004218 |
754 | REGULATION OF PROTEIN STABILITY | 8 | 221 | 0.0007223 | 0.004458 |
755 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 6 | 123 | 0.0007297 | 0.004497 |
756 | MUSCLE ORGAN DEVELOPMENT | 9 | 277 | 0.000737 | 0.00452 |
757 | THYMUS DEVELOPMENT | 4 | 47 | 0.0007373 | 0.00452 |
758 | MUSCLE FIBER DEVELOPMENT | 4 | 47 | 0.0007373 | 0.00452 |
759 | RESPONSE TO ANTIBIOTIC | 4 | 47 | 0.0007373 | 0.00452 |
760 | KIDNEY MORPHOGENESIS | 5 | 82 | 0.0007477 | 0.004578 |
761 | TISSUE HOMEOSTASIS | 7 | 171 | 0.0007578 | 0.004634 |
762 | B CELL HOMEOSTASIS | 3 | 21 | 0.000767 | 0.004665 |
763 | NECROPTOTIC PROCESS | 3 | 21 | 0.000767 | 0.004665 |
764 | T HELPER 1 TYPE IMMUNE RESPONSE | 3 | 21 | 0.000767 | 0.004665 |
765 | BONE RESORPTION | 3 | 21 | 0.000767 | 0.004665 |
766 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 12 | 465 | 0.0007927 | 0.004815 |
767 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 4 | 48 | 0.000799 | 0.004847 |
768 | MUSCLE SYSTEM PROCESS | 9 | 282 | 0.0008364 | 0.005067 |
769 | CELLULAR HOMEOSTASIS | 15 | 676 | 0.0008584 | 0.005194 |
770 | REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 4 | 49 | 0.0008641 | 0.005202 |
771 | GLOMERULUS DEVELOPMENT | 4 | 49 | 0.0008641 | 0.005202 |
772 | CELLULAR RESPONSE TO CALCIUM ION | 4 | 49 | 0.0008641 | 0.005202 |
773 | REGULATION OF STEROID BIOSYNTHETIC PROCESS | 4 | 49 | 0.0008641 | 0.005202 |
774 | DIVALENT INORGANIC CATION HOMEOSTASIS | 10 | 343 | 0.00087 | 0.00523 |
775 | EPHRIN RECEPTOR SIGNALING PATHWAY | 5 | 85 | 0.0008802 | 0.005264 |
776 | POSITIVE REGULATION OF CHROMATIN MODIFICATION | 5 | 85 | 0.0008802 | 0.005264 |
777 | HEART PROCESS | 5 | 85 | 0.0008802 | 0.005264 |
778 | POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 5 | 85 | 0.0008802 | 0.005264 |
779 | CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 3 | 22 | 0.0008825 | 0.005264 |
780 | POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 3 | 22 | 0.0008825 | 0.005264 |
781 | REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 6 | 128 | 0.0008987 | 0.005354 |
782 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 14 | 609 | 0.0009115 | 0.005423 |
783 | MITOCHONDRIAL TRANSPORT | 7 | 177 | 0.0009278 | 0.005513 |
784 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 4 | 50 | 0.0009329 | 0.005523 |
785 | RESPONSE TO PROGESTERONE | 4 | 50 | 0.0009329 | 0.005523 |
786 | ENDODERM FORMATION | 4 | 50 | 0.0009329 | 0.005523 |
787 | NUCLEAR IMPORT | 6 | 129 | 0.0009359 | 0.005533 |
788 | ALCOHOL METABOLIC PROCESS | 10 | 348 | 0.0009708 | 0.005732 |
789 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 8 | 232 | 0.0009892 | 0.005834 |
790 | POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS | 4 | 51 | 0.001006 | 0.005917 |
791 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 23 | 0.001008 | 0.005917 |
792 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 3 | 23 | 0.001008 | 0.005917 |
793 | POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 3 | 23 | 0.001008 | 0.005917 |
794 | PROTEIN STABILIZATION | 6 | 131 | 0.001014 | 0.005941 |
795 | LEUKOCYTE ACTIVATION | 11 | 414 | 0.001034 | 0.006051 |
796 | POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 4 | 52 | 0.001082 | 0.006325 |
797 | REGULATION OF INFLAMMATORY RESPONSE | 9 | 294 | 0.00112 | 0.006539 |
798 | REGULATION OF HISTONE DEACETYLATION | 3 | 24 | 0.001145 | 0.006619 |
799 | NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 3 | 24 | 0.001145 | 0.006619 |
800 | REGULATION OF OXIDOREDUCTASE ACTIVITY | 5 | 90 | 0.001139 | 0.006619 |
801 | MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 6 | 134 | 0.00114 | 0.006619 |
802 | POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 3 | 24 | 0.001145 | 0.006619 |
803 | NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 3 | 24 | 0.001145 | 0.006619 |
804 | POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 3 | 24 | 0.001145 | 0.006619 |
805 | REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 3 | 24 | 0.001145 | 0.006619 |
806 | SECRETION BY CELL | 12 | 486 | 0.001159 | 0.006686 |
807 | REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS | 4 | 53 | 0.001162 | 0.006686 |
808 | CYTOSOLIC CALCIUM ION TRANSPORT | 4 | 53 | 0.001162 | 0.006686 |
809 | CELLULAR RESPONSE TO AMINO ACID STIMULUS | 4 | 53 | 0.001162 | 0.006686 |
810 | NEUROLOGICAL SYSTEM PROCESS | 22 | 1242 | 0.001179 | 0.006773 |
811 | REGULATION OF CELL CYCLE PROCESS | 13 | 558 | 0.00123 | 0.007059 |
812 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 4 | 54 | 0.001247 | 0.007146 |
813 | CIRCADIAN RHYTHM | 6 | 137 | 0.001277 | 0.007293 |
814 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 6 | 137 | 0.001277 | 0.007293 |
815 | CELLULAR RESPONSE TO RADIATION | 6 | 137 | 0.001277 | 0.007293 |
816 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 5 | 93 | 0.001319 | 0.007521 |
817 | POSITIVE REGULATION OF PROTEOLYSIS | 10 | 363 | 0.001332 | 0.007587 |
818 | NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 4 | 55 | 0.001336 | 0.007589 |
819 | REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 4 | 55 | 0.001336 | 0.007589 |
820 | RESPONSE TO ORGANOPHOSPHORUS | 6 | 139 | 0.001376 | 0.007798 |
821 | MITOTIC CELL CYCLE CHECKPOINT | 6 | 139 | 0.001376 | 0.007798 |
822 | NEURAL TUBE FORMATION | 5 | 94 | 0.001383 | 0.007831 |
823 | NON CANONICAL WNT SIGNALING PATHWAY | 6 | 140 | 0.001427 | 0.008059 |
824 | NEURON NEURON SYNAPTIC TRANSMISSION | 4 | 56 | 0.001429 | 0.008059 |
825 | OUTFLOW TRACT MORPHOGENESIS | 4 | 56 | 0.001429 | 0.008059 |
826 | REGULATION OF CELL FATE COMMITMENT | 3 | 26 | 0.001452 | 0.008182 |
827 | IMMUNE RESPONSE | 20 | 1100 | 0.001461 | 0.008219 |
828 | LIPID CATABOLIC PROCESS | 8 | 247 | 0.001475 | 0.008286 |
829 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 9 | 306 | 0.001477 | 0.00829 |
830 | ICOSANOID METABOLIC PROCESS | 5 | 96 | 0.001519 | 0.008497 |
831 | FEMALE GAMETE GENERATION | 5 | 96 | 0.001519 | 0.008497 |
832 | FATTY ACID DERIVATIVE METABOLIC PROCESS | 5 | 96 | 0.001519 | 0.008497 |
833 | MYOTUBE DIFFERENTIATION | 4 | 57 | 0.001526 | 0.008527 |
834 | DEVELOPMENTAL MATURATION | 7 | 193 | 0.00153 | 0.008537 |
835 | EPIDERMAL CELL DIFFERENTIATION | 6 | 142 | 0.001535 | 0.008552 |
836 | REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 97 | 0.001591 | 0.008854 |
837 | REGULATION OF WNT SIGNALING PATHWAY | 9 | 310 | 0.001615 | 0.008952 |
838 | HIPPO SIGNALING | 3 | 27 | 0.001624 | 0.008952 |
839 | NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 3 | 27 | 0.001624 | 0.008952 |
840 | CATION TRANSPORT | 16 | 796 | 0.001624 | 0.008952 |
841 | EXCITATORY POSTSYNAPTIC POTENTIAL | 3 | 27 | 0.001624 | 0.008952 |
842 | REGULATION OF FATTY ACID TRANSPORT | 3 | 27 | 0.001624 | 0.008952 |
843 | RESPONSE TO LITHIUM ION | 3 | 27 | 0.001624 | 0.008952 |
844 | AXIS ELONGATION | 3 | 27 | 0.001624 | 0.008952 |
845 | NEGATIVE REGULATION OF WOUND HEALING | 4 | 58 | 0.001629 | 0.008968 |
846 | ION HOMEOSTASIS | 13 | 576 | 0.001632 | 0.008975 |
847 | NEGATIVE REGULATION OF DEFENSE RESPONSE | 6 | 144 | 0.001648 | 0.009053 |
848 | CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 8 | 252 | 0.001673 | 0.009179 |
849 | VASCULOGENESIS | 4 | 59 | 0.001735 | 0.00951 |
850 | STRIATED MUSCLE CONTRACTION | 5 | 99 | 0.001741 | 0.009531 |
851 | POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 3 | 28 | 0.001807 | 0.009856 |
852 | REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 3 | 28 | 0.001807 | 0.009856 |
853 | NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 3 | 28 | 0.001807 | 0.009856 |
854 | LIMBIC SYSTEM DEVELOPMENT | 5 | 100 | 0.00182 | 0.009916 |
855 | REGULATION OF T CELL PROLIFERATION | 6 | 147 | 0.00183 | 0.009957 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY | 35 | 92 | 4.039e-49 | 3.752e-46 |
2 | PROTEIN KINASE ACTIVITY | 60 | 640 | 1.409e-45 | 6.547e-43 |
3 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 50 | 445 | 1.735e-41 | 5.372e-39 |
4 | KINASE ACTIVITY | 62 | 842 | 7.035e-41 | 1.634e-38 |
5 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 36 | 172 | 8.713e-40 | 1.619e-37 |
6 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 62 | 992 | 1.095e-36 | 1.696e-34 |
7 | RIBONUCLEOTIDE BINDING | 72 | 1860 | 1.285e-29 | 1.705e-27 |
8 | ADENYL NUCLEOTIDE BINDING | 63 | 1514 | 3.407e-27 | 3.956e-25 |
9 | KINASE BINDING | 40 | 606 | 4.611e-24 | 4.76e-22 |
10 | ENZYME BINDING | 62 | 1737 | 3.781e-23 | 3.512e-21 |
11 | MAP KINASE KINASE KINASE ACTIVITY | 12 | 22 | 7.678e-20 | 6.484e-18 |
12 | SIGNAL TRANSDUCER ACTIVITY | 57 | 1731 | 1.887e-19 | 1.461e-17 |
13 | MAP KINASE PHOSPHATASE ACTIVITY | 10 | 14 | 1.859e-18 | 1.328e-16 |
14 | PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 19 | 178 | 1.381e-15 | 9.166e-14 |
15 | MOLECULAR FUNCTION REGULATOR | 45 | 1353 | 2.398e-15 | 1.485e-13 |
16 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 20 | 228 | 1.081e-14 | 6.275e-13 |
17 | VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 11 | 42 | 5.325e-14 | 2.91e-12 |
18 | PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 11 | 45 | 1.235e-13 | 6.371e-12 |
19 | PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 14 | 103 | 2.949e-13 | 1.442e-11 |
20 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 12 | 70 | 8.809e-13 | 4.092e-11 |
21 | HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 7 | 11 | 1.071e-12 | 4.738e-11 |
22 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 20 | 303 | 2.272e-12 | 9.596e-11 |
23 | PROTEIN TYROSINE KINASE ACTIVITY | 16 | 176 | 3.226e-12 | 1.303e-10 |
24 | PHOSPHATASE ACTIVITY | 19 | 275 | 3.736e-12 | 1.446e-10 |
25 | GROWTH FACTOR ACTIVITY | 15 | 160 | 1.011e-11 | 3.756e-10 |
26 | MAP KINASE ACTIVITY | 7 | 14 | 1.09e-11 | 3.893e-10 |
27 | RECEPTOR BINDING | 41 | 1476 | 1.875e-11 | 6.451e-10 |
28 | GROWTH FACTOR BINDING | 13 | 123 | 5.577e-11 | 1.85e-09 |
29 | PHOSPHOLIPASE A2 ACTIVITY | 8 | 31 | 1.857e-10 | 5.95e-09 |
30 | MAGNESIUM ION BINDING | 15 | 199 | 2.278e-10 | 7.055e-09 |
31 | HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 27 | 739 | 2.663e-10 | 7.981e-09 |
32 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 19 | 368 | 5.572e-10 | 1.618e-08 |
33 | PROTEIN DIMERIZATION ACTIVITY | 33 | 1149 | 1.108e-09 | 3.119e-08 |
34 | CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 128 | 1.271e-09 | 3.472e-08 |
35 | PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 8 | 39 | 1.365e-09 | 3.624e-08 |
36 | PROTEIN HETERODIMERIZATION ACTIVITY | 20 | 468 | 4.996e-09 | 1.289e-07 |
37 | DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 167 | 2.62e-08 | 6.404e-07 |
38 | VOLTAGE GATED CATION CHANNEL ACTIVITY | 11 | 134 | 2.565e-08 | 6.404e-07 |
39 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 9 | 81 | 3.537e-08 | 8.238e-07 |
40 | MAP KINASE KINASE ACTIVITY | 5 | 12 | 3.547e-08 | 8.238e-07 |
41 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 8 | 64 | 8.165e-08 | 1.83e-06 |
42 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 43 | 8.273e-08 | 1.83e-06 |
43 | VOLTAGE GATED ION CHANNEL ACTIVITY | 12 | 190 | 1.09e-07 | 2.355e-06 |
44 | PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 5 | 15 | 1.317e-07 | 2.78e-06 |
45 | ENZYME ACTIVATOR ACTIVITY | 18 | 471 | 1.644e-07 | 3.395e-06 |
46 | GROWTH FACTOR RECEPTOR BINDING | 10 | 129 | 1.932e-07 | 3.903e-06 |
47 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 7 | 51 | 2.803e-07 | 5.541e-06 |
48 | MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 5 | 18 | 3.678e-07 | 7.119e-06 |
49 | MACROMOLECULAR COMPLEX BINDING | 32 | 1399 | 4.168e-07 | 7.901e-06 |
50 | PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 5 | 19 | 4.957e-07 | 9.21e-06 |
51 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 13 | 264 | 5.665e-07 | 1.032e-05 |
52 | ENZYME REGULATOR ACTIVITY | 25 | 959 | 9.056e-07 | 1.618e-05 |
53 | KINASE ACTIVATOR ACTIVITY | 7 | 62 | 1.099e-06 | 1.926e-05 |
54 | HEPARIN BINDING | 10 | 157 | 1.193e-06 | 2.053e-05 |
55 | PROTEIN HOMODIMERIZATION ACTIVITY | 21 | 722 | 1.332e-06 | 2.251e-05 |
56 | PHOSPHOLIPASE ACTIVITY | 8 | 94 | 1.646e-06 | 2.73e-05 |
57 | DIACYLGLYCEROL BINDING | 4 | 11 | 1.741e-06 | 2.789e-05 |
58 | PLATELET DERIVED GROWTH FACTOR BINDING | 4 | 11 | 1.741e-06 | 2.789e-05 |
59 | GLYCOSAMINOGLYCAN BINDING | 11 | 205 | 1.879e-06 | 2.958e-05 |
60 | IDENTICAL PROTEIN BINDING | 28 | 1209 | 1.941e-06 | 3.005e-05 |
61 | PROTEIN DOMAIN SPECIFIC BINDING | 19 | 624 | 2.271e-06 | 3.459e-05 |
62 | CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 4 | 12 | 2.594e-06 | 3.887e-05 |
63 | TRANSCRIPTION FACTOR BINDING | 17 | 524 | 3.461e-06 | 5.104e-05 |
64 | FIBROBLAST GROWTH FACTOR RECEPTOR BINDING | 5 | 28 | 3.932e-06 | 5.708e-05 |
65 | KINASE REGULATOR ACTIVITY | 10 | 186 | 5.484e-06 | 7.838e-05 |
66 | LIPASE ACTIVITY | 8 | 117 | 8.51e-06 | 0.0001198 |
67 | MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 4 | 16 | 9.283e-06 | 0.0001287 |
68 | CATION CHANNEL ACTIVITY | 12 | 298 | 1.224e-05 | 0.0001672 |
69 | HISTONE KINASE ACTIVITY | 4 | 19 | 1.937e-05 | 0.0002608 |
70 | PROTEIN COMPLEX BINDING | 22 | 935 | 2.159e-05 | 0.0002865 |
71 | CARBOXYLIC ESTER HYDROLASE ACTIVITY | 8 | 135 | 2.421e-05 | 0.0003168 |
72 | CYTOKINE RECEPTOR BINDING | 11 | 271 | 2.643e-05 | 0.000341 |
73 | GATED CHANNEL ACTIVITY | 12 | 325 | 2.884e-05 | 0.0003671 |
74 | CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 5 | 42 | 3.084e-05 | 0.0003872 |
75 | SULFUR COMPOUND BINDING | 10 | 234 | 4.009e-05 | 0.0004966 |
76 | FIBROBLAST GROWTH FACTOR BINDING | 4 | 23 | 4.307e-05 | 0.0005264 |
77 | MITOGEN ACTIVATED PROTEIN KINASE BINDING | 4 | 24 | 5.133e-05 | 0.0006193 |
78 | TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 5 | 47 | 5.37e-05 | 0.0006395 |
79 | CHEMOATTRACTANT ACTIVITY | 4 | 27 | 8.307e-05 | 0.0009768 |
80 | HEAT SHOCK PROTEIN BINDING | 6 | 89 | 0.0001272 | 0.001477 |
81 | CHANNEL REGULATOR ACTIVITY | 7 | 131 | 0.0001509 | 0.00173 |
82 | CALMODULIN BINDING | 8 | 179 | 0.0001765 | 0.001999 |
83 | NEUROTROPHIN RECEPTOR BINDING | 3 | 14 | 0.0002195 | 0.002457 |
84 | METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 417 | 0.0003019 | 0.003339 |
85 | HISTONE DEACETYLASE BINDING | 6 | 105 | 0.0003142 | 0.003434 |
86 | SMAD BINDING | 5 | 72 | 0.0004111 | 0.00434 |
87 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 15 | 629 | 0.0004098 | 0.00434 |
88 | GTP DEPENDENT PROTEIN BINDING | 3 | 17 | 0.0004023 | 0.00434 |
89 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 10 | 315 | 0.0004515 | 0.004713 |
90 | DEATH RECEPTOR BINDING | 3 | 18 | 0.0004797 | 0.004952 |
91 | ADRENERGIC RECEPTOR BINDING | 3 | 19 | 0.000566 | 0.005779 |
92 | SCAFFOLD PROTEIN BINDING | 4 | 45 | 0.0006243 | 0.006304 |
93 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 464 | 0.000778 | 0.007772 |
94 | REGULATORY REGION NUCLEIC ACID BINDING | 17 | 818 | 0.0008086 | 0.007991 |
95 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 8 | 226 | 0.0008353 | 0.008168 |
96 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 4 | 50 | 0.0009329 | 0.009028 |
97 | R SMAD BINDING | 3 | 23 | 0.001008 | 0.009559 |
98 | CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 3 | 23 | 0.001008 | 0.009559 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 13 | 40 | 1.019e-17 | 5.952e-15 |
2 | CALCIUM CHANNEL COMPLEX | 14 | 62 | 1.695e-16 | 4.95e-14 |
3 | CATION CHANNEL COMPLEX | 14 | 167 | 2.278e-10 | 4.434e-08 |
4 | PLASMA MEMBRANE PROTEIN COMPLEX | 22 | 510 | 6.736e-10 | 9.835e-08 |
5 | CYTOPLASMIC SIDE OF MEMBRANE | 12 | 170 | 3.195e-08 | 3.731e-06 |
6 | CELL SUBSTRATE JUNCTION | 17 | 398 | 7.639e-08 | 7.436e-06 |
7 | SARCOLEMMA | 10 | 125 | 1.436e-07 | 1.198e-05 |
8 | SIDE OF MEMBRANE | 17 | 428 | 2.15e-07 | 1.57e-05 |
9 | PERINUCLEAR REGION OF CYTOPLASM | 20 | 642 | 8.481e-07 | 5.161e-05 |
10 | TRANSPORTER COMPLEX | 14 | 321 | 8.838e-07 | 5.161e-05 |
11 | PROTEIN KINASE COMPLEX | 8 | 90 | 1.18e-06 | 6.201e-05 |
12 | INTRACELLULAR VESICLE | 29 | 1259 | 1.38e-06 | 6.201e-05 |
13 | ANCHORING JUNCTION | 17 | 489 | 1.364e-06 | 6.201e-05 |
14 | IKAPPAB KINASE COMPLEX | 4 | 11 | 1.741e-06 | 7.264e-05 |
15 | SOMATODENDRITIC COMPARTMENT | 19 | 650 | 4.104e-06 | 0.0001598 |
16 | NEURON PROJECTION | 23 | 942 | 7.611e-06 | 0.0002778 |
17 | MEMBRANE PROTEIN COMPLEX | 24 | 1020 | 8.806e-06 | 0.0003025 |
18 | NEURON PART | 27 | 1265 | 1.349e-05 | 0.0004376 |
19 | ACTIN FILAMENT | 6 | 70 | 3.289e-05 | 0.001011 |
20 | VESICLE LUMEN | 7 | 106 | 3.951e-05 | 0.001154 |
21 | T TUBULE | 5 | 45 | 4.337e-05 | 0.001206 |
22 | EXCITATORY SYNAPSE | 9 | 197 | 5.866e-05 | 0.001557 |
23 | PLATELET ALPHA GRANULE LUMEN | 5 | 55 | 0.0001151 | 0.002923 |
24 | CELL PROJECTION | 31 | 1786 | 0.0001528 | 0.003718 |
25 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 9 | 237 | 0.0002378 | 0.005555 |
26 | INTRINSIC COMPONENT OF THE CYTOPLASMIC SIDE OF THE PLASMA MEMBRANE | 3 | 15 | 0.0002727 | 0.006125 |
27 | CYTOSKELETAL PART | 26 | 1436 | 0.0002927 | 0.006331 |
28 | CYTOSKELETON | 32 | 1967 | 0.0003791 | 0.007907 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04010_MAPK_signaling_pathway | 174 | 268 | 0 | 0 | |
2 | hsa04014_Ras_signaling_pathway | 65 | 236 | 6.506e-82 | 5.856e-80 | |
3 | hsa04912_GnRH_signaling_pathway | 36 | 101 | 2.762e-49 | 1.657e-47 | |
4 | hsa04722_Neurotrophin_signaling_pathway | 37 | 127 | 7.76e-47 | 3.492e-45 | |
5 | hsa04664_Fc_epsilon_RI_signaling_pathway | 31 | 79 | 4.984e-44 | 1.794e-42 | |
6 | hsa04370_VEGF_signaling_pathway | 29 | 76 | 8.984e-41 | 2.695e-39 | |
7 | hsa04660_T_cell_receptor_signaling_pathway | 28 | 108 | 7.145e-34 | 1.837e-32 | |
8 | hsa04151_PI3K_AKT_signaling_pathway | 40 | 351 | 3.073e-33 | 6.914e-32 | |
9 | hsa04810_Regulation_of_actin_cytoskeleton | 33 | 214 | 7.925e-32 | 1.585e-30 | |
10 | hsa04662_B_cell_receptor_signaling_pathway | 24 | 75 | 1.211e-31 | 2.18e-30 | |
11 | hsa04380_Osteoclast_differentiation | 28 | 128 | 1.384e-31 | 2.264e-30 | |
12 | hsa04012_ErbB_signaling_pathway | 21 | 87 | 7.203e-25 | 1.08e-23 | |
13 | hsa04510_Focal_adhesion | 27 | 200 | 1.607e-24 | 2.225e-23 | |
14 | hsa04620_Toll.like_receptor_signaling_pathway | 21 | 102 | 2.763e-23 | 3.552e-22 | |
15 | hsa04210_Apoptosis | 20 | 89 | 4.773e-23 | 5.727e-22 | |
16 | hsa04540_Gap_junction | 20 | 90 | 6.091e-23 | 6.852e-22 | |
17 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 22 | 136 | 6.567e-22 | 6.954e-21 | |
18 | hsa04720_Long.term_potentiation | 17 | 70 | 2.233e-20 | 2.116e-19 | |
19 | hsa04730_Long.term_depression | 17 | 70 | 2.233e-20 | 2.116e-19 | |
20 | hsa04062_Chemokine_signaling_pathway | 23 | 189 | 5.867e-20 | 5.28e-19 | |
21 | hsa04310_Wnt_signaling_pathway | 21 | 151 | 1.549e-19 | 1.328e-18 | |
22 | hsa04270_Vascular_smooth_muscle_contraction | 19 | 116 | 3.649e-19 | 2.985e-18 | |
23 | hsa04914_Progesterone.mediated_oocyte_maturation | 16 | 87 | 3.708e-17 | 2.902e-16 | |
24 | hsa04910_Insulin_signaling_pathway | 18 | 138 | 2.188e-16 | 1.641e-15 | |
25 | hsa00592_alpha.Linolenic_acid_metabolism | 9 | 20 | 3.587e-14 | 2.582e-13 | |
26 | hsa04144_Endocytosis | 18 | 203 | 2.055e-13 | 1.423e-12 | |
27 | hsa04622_RIG.I.like_receptor_signaling_pathway | 12 | 71 | 1.052e-12 | 7.014e-12 | |
28 | hsa00591_Linoleic_acid_metabolism | 9 | 30 | 2.836e-12 | 1.823e-11 | |
29 | hsa04621_NOD.like_receptor_signaling_pathway | 11 | 59 | 3.064e-12 | 1.902e-11 | |
30 | hsa04020_Calcium_signaling_pathway | 16 | 177 | 3.52e-12 | 2.112e-11 | |
31 | hsa00565_Ether_lipid_metabolism | 9 | 36 | 1.784e-11 | 1.036e-10 | |
32 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 12 | 95 | 3.751e-11 | 2.11e-10 | |
33 | hsa04972_Pancreatic_secretion | 12 | 101 | 7.82e-11 | 4.266e-10 | |
34 | hsa04360_Axon_guidance | 13 | 130 | 1.127e-10 | 5.966e-10 | |
35 | hsa04975_Fat_digestion_and_absorption | 9 | 46 | 1.938e-10 | 9.969e-10 | |
36 | hsa04920_Adipocytokine_signaling_pathway | 10 | 68 | 3.604e-10 | 1.802e-09 | |
37 | hsa00590_Arachidonic_acid_metabolism | 9 | 59 | 2.007e-09 | 9.763e-09 | |
38 | hsa04916_Melanogenesis | 10 | 101 | 1.861e-08 | 8.815e-08 | |
39 | hsa04260_Cardiac_muscle_contraction | 9 | 77 | 2.253e-08 | 1.04e-07 | |
40 | hsa00564_Glycerophospholipid_metabolism | 9 | 80 | 3.168e-08 | 1.426e-07 | |
41 | hsa04114_Oocyte_meiosis | 10 | 114 | 5.982e-08 | 2.626e-07 | |
42 | hsa04520_Adherens_junction | 8 | 73 | 2.32e-07 | 9.944e-07 | |
43 | hsa04110_Cell_cycle | 9 | 128 | 1.823e-06 | 7.63e-06 | |
44 | hsa04320_Dorso.ventral_axis_formation | 5 | 25 | 2.171e-06 | 8.825e-06 | |
45 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 10 | 168 | 2.206e-06 | 8.825e-06 | |
46 | hsa04530_Tight_junction | 9 | 133 | 2.507e-06 | 9.811e-06 | |
47 | hsa04115_p53_signaling_pathway | 6 | 69 | 3.029e-05 | 0.000116 | |
48 | hsa04612_Antigen_processing_and_presentation | 6 | 78 | 6.084e-05 | 0.0002281 | |
49 | hsa04150_mTOR_signaling_pathway | 5 | 52 | 8.784e-05 | 0.0003227 | |
50 | hsa04350_TGF.beta_signaling_pathway | 6 | 85 | 9.852e-05 | 0.0003547 | |
51 | hsa04390_Hippo_signaling_pathway | 7 | 154 | 0.0004061 | 0.001433 | |
52 | hsa04971_Gastric_acid_secretion | 5 | 74 | 0.0004668 | 0.001616 | |
53 | hsa04670_Leukocyte_transendothelial_migration | 6 | 117 | 0.0005605 | 0.001904 | |
54 | hsa04973_Carbohydrate_digestion_and_absorption | 4 | 44 | 0.0005727 | 0.001909 | |
55 | hsa04970_Salivary_secretion | 5 | 89 | 0.001083 | 0.003545 | |
56 | hsa03040_Spliceosome | 5 | 128 | 0.005268 | 0.01693 | |
57 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 3 | 42 | 0.005793 | 0.01829 | |
58 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.006599 | 0.02048 | |
59 | hsa04742_Taste_transduction | 3 | 52 | 0.01047 | 0.03194 | |
60 | hsa04630_Jak.STAT_signaling_pathway | 5 | 155 | 0.01155 | 0.03464 | |
61 | hsa04340_Hedgehog_signaling_pathway | 3 | 56 | 0.0128 | 0.03717 | |
62 | hsa04623_Cytosolic_DNA.sensing_pathway | 3 | 56 | 0.0128 | 0.03717 | |
63 | hsa04976_Bile_secretion | 3 | 71 | 0.02403 | 0.06865 | |
64 | hsa04744_Phototransduction | 2 | 29 | 0.0262 | 0.07368 | |
65 | hsa04672_Intestinal_immune_network_for_IgA_production | 2 | 49 | 0.06784 | 0.1879 | |
66 | hsa04070_Phosphatidylinositol_signaling_system | 2 | 78 | 0.1477 | 0.4028 | |
67 | hsa04640_Hematopoietic_cell_lineage | 2 | 88 | 0.1783 | 0.4791 | |
68 | hsa04120_Ubiquitin_mediated_proteolysis | 2 | 139 | 0.3413 | 0.9035 | |
69 | hsa04740_Olfactory_transduction | 4 | 388 | 0.4374 | 1 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | DHRS4-AS1 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181b-5p;hsa-miR-20a-5p;hsa-miR-339-5p;hsa-miR-500a-5p;hsa-miR-502-5p;hsa-miR-582-5p;hsa-miR-877-5p | 11 | MAP3K13 | Sponge network | -0.646 | 0.01829 | -0.449 | 0.05753 | 0.668 |
2 | HCG11 |
hsa-miR-107;hsa-miR-130b-3p;hsa-miR-130b-5p;hsa-miR-148a-5p;hsa-miR-151a-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-421;hsa-miR-618 | 10 | NTRK2 | Sponge network | -0.781 | 0 | -2.305 | 0 | 0.582 |
3 | HCG11 |
hsa-miR-106b-5p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-17-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-362-3p;hsa-miR-502-3p;hsa-miR-93-5p | 10 | AKT3 | Sponge network | -0.781 | 0 | -0.659 | 0.00047 | 0.574 |
4 | LINC00176 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 13 | CACNB4 | Sponge network | 3.423 | 0 | 1.931 | 0 | 0.532 |
5 | MIR4435-1HG |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-450b-5p;hsa-miR-505-5p;hsa-miR-7-1-3p;hsa-miR-874-3p | 12 | MAPT | Sponge network | 2.541 | 0 | 2.585 | 0 | 0.504 |
6 | RP11-545I5.3 | hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-324-5p;hsa-miR-339-5p;hsa-miR-455-5p;hsa-miR-769-3p;hsa-miR-93-5p | 10 | TAOK1 | Sponge network | 0.139 | 0.66524 | -0.396 | 0.0493 | 0.474 |
7 | HCG11 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-93-5p | 10 | TGFBR2 | Sponge network | -0.781 | 0 | -0.523 | 3.0E-5 | 0.472 |
8 | LINC00152 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-450b-5p;hsa-miR-505-5p;hsa-miR-874-3p | 10 | MAPT | Sponge network | 2.553 | 0 | 2.585 | 0 | 0.463 |
9 | MAFG-AS1 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-505-5p;hsa-miR-874-3p | 11 | MAPT | Sponge network | 2.966 | 0 | 2.585 | 0 | 0.442 |
10 | RP11-600F24.7 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-505-5p;hsa-miR-874-3p | 11 | MAPT | Sponge network | 2.603 | 0 | 2.585 | 0 | 0.43 |
11 | MAGI2-AS3 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-92a-3p;hsa-miR-93-5p | 11 | TGFBR2 | Sponge network | -1.801 | 0 | -0.523 | 3.0E-5 | 0.428 |
12 | RP11-727A23.5 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-450b-5p | 10 | MAPT | Sponge network | 1.435 | 0 | 2.585 | 0 | 0.419 |
13 | DHRS4-AS1 |
hsa-miR-140-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-20a-5p;hsa-miR-29a-5p;hsa-miR-339-5p;hsa-miR-501-5p;hsa-miR-502-5p;hsa-miR-769-3p | 10 | TAOK1 | Sponge network | -0.646 | 0.01829 | -0.396 | 0.0493 | 0.419 |
14 | RP11-196G18.22 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-505-5p | 10 | MAPT | Sponge network | 2.705 | 0 | 2.585 | 0 | 0.411 |
15 | RP11-284F21.9 |
hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-450b-5p;hsa-miR-505-5p | 10 | MAPT | Sponge network | 4.745 | 0 | 2.585 | 0 | 0.407 |
16 | RP11-196G18.22 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-505-3p | 11 | CACNB4 | Sponge network | 2.705 | 0 | 1.931 | 0 | 0.405 |
17 | AP006222.2 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-378a-5p | 16 | CACNA1E | Sponge network | 1.709 | 0 | 1.613 | 4.0E-5 | 0.405 |
18 | RP11-12A2.3 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-339-5p;hsa-miR-877-5p;hsa-miR-93-5p | 11 | MAP3K13 | Sponge network | -4.779 | 0 | -0.449 | 0.05753 | 0.403 |
19 | RP11-12A2.3 |
hsa-miR-106b-5p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-30d-5p;hsa-miR-338-3p;hsa-miR-93-5p | 14 | MAP3K2 | Sponge network | -4.779 | 0 | -0.771 | 0 | 0.398 |
20 | LINC00176 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-450b-5p;hsa-miR-505-5p;hsa-miR-874-3p | 10 | MAPT | Sponge network | 3.423 | 0 | 2.585 | 0 | 0.395 |
21 | RP11-196G18.24 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p | 11 | CACNB4 | Sponge network | 2.972 | 0 | 1.931 | 0 | 0.394 |
22 | AC025171.1 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-450b-5p;hsa-miR-874-3p | 10 | MAPT | Sponge network | 2.476 | 0 | 2.585 | 0 | 0.387 |
23 | PRKAR2A-AS1 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-495-3p;hsa-miR-874-3p | 11 | MAPT | Sponge network | 2.366 | 0 | 2.585 | 0 | 0.383 |
24 | HNRNPU-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p;hsa-miR-542-3p | 12 | CACNB4 | Sponge network | 1.246 | 0 | 1.931 | 0 | 0.379 |
25 | AP001469.9 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-874-3p | 10 | MAPT | Sponge network | 2.428 | 0 | 2.585 | 0 | 0.379 |
26 | RP11-480I12.7 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-424-5p;hsa-miR-497-5p | 12 | CACNB4 | Sponge network | 2.03 | 0 | 1.931 | 0 | 0.377 |
27 | LINC01018 | hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-421;hsa-miR-432-5p;hsa-miR-877-5p;hsa-miR-93-5p | 10 | MAP3K13 | Sponge network | -3.231 | 0 | -0.449 | 0.05753 | 0.374 |
28 | ATP6V0E2-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-20a-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p | 10 | CACNB4 | Sponge network | 1.885 | 0 | 1.931 | 0 | 0.364 |
29 | RP4-717I23.3 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-505-5p | 10 | MAPT | Sponge network | 1.867 | 0 | 2.585 | 0 | 0.362 |
30 | AC012146.7 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 1.709 | 0 | 1.931 | 0 | 0.353 |
31 | MIR4435-1HG |
hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-7-1-3p | 20 | CACNA1E | Sponge network | 2.541 | 0 | 1.613 | 4.0E-5 | 0.353 |
32 | AC005154.6 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-450b-5p;hsa-miR-505-5p | 10 | MAPT | Sponge network | 1.75 | 0 | 2.585 | 0 | 0.35 |
33 | RP11-727A23.5 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 1.435 | 0 | 1.931 | 0 | 0.349 |
34 | PART1 | hsa-let-7b-5p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 3.525 | 1.0E-5 | 1.931 | 0 | 0.348 |
35 | DLGAP1-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 0.91 | 0 | 1.931 | 0 | 0.345 |
36 | RP11-121C2.2 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p | 10 | CACNB4 | Sponge network | 1.286 | 0 | 1.931 | 0 | 0.345 |
37 | LINC00152 |
hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 18 | CACNA1E | Sponge network | 2.553 | 0 | 1.613 | 4.0E-5 | 0.343 |
38 | PRKAR2A-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 2.366 | 0 | 1.931 | 0 | 0.341 |
39 | AC074117.10 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p;hsa-miR-542-3p | 13 | CACNB4 | Sponge network | 1.254 | 0 | 1.931 | 0 | 0.336 |
40 | AC016747.3 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 13 | CACNB4 | Sponge network | 1.235 | 0 | 1.931 | 0 | 0.332 |
41 | RP11-600F24.7 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p;hsa-miR-542-3p | 13 | CACNB4 | Sponge network | 2.603 | 0 | 1.931 | 0 | 0.332 |
42 | RP11-465N4.4 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-3614-5p;hsa-miR-424-5p;hsa-miR-497-5p | 17 | CACNA1E | Sponge network | 1.938 | 0 | 1.613 | 4.0E-5 | 0.327 |
43 | RP11-295G20.2 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p | 12 | CACNA1E | Sponge network | 2.208 | 0 | 1.613 | 4.0E-5 | 0.326 |
44 | RP11-495P10.5 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-505-3p;hsa-miR-542-3p | 12 | CACNB4 | Sponge network | 7.839 | 0 | 1.931 | 0 | 0.326 |
45 | AC005562.1 |
hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 1.127 | 0 | 1.931 | 0 | 0.326 |
46 | RP11-166D19.1 |
hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-301a-3p;hsa-miR-590-5p;hsa-miR-92a-3p | 11 | TGFBR2 | Sponge network | -0.244 | 0.28835 | -0.523 | 3.0E-5 | 0.324 |
47 | TPT1-AS1 | hsa-let-7a-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-28-5p;hsa-miR-30e-3p;hsa-miR-378a-5p | 10 | CACNA1E | Sponge network | 0.45 | 2.0E-5 | 1.613 | 4.0E-5 | 0.324 |
48 | RP4-717I23.3 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-505-3p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 1.867 | 0 | 1.931 | 0 | 0.316 |
49 | RP5-1074L1.4 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p | 10 | CACNB4 | Sponge network | 2.302 | 0 | 1.931 | 0 | 0.315 |
50 | RP11-536K7.3 | hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-3065-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p | 12 | CACNA1E | Sponge network | 1.961 | 0 | 1.613 | 4.0E-5 | 0.315 |
51 | BMS1P20 | hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p | 12 | CACNA1E | Sponge network | 1.015 | 0 | 1.613 | 4.0E-5 | 0.311 |
52 | RP11-783K16.13 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-378a-5p | 10 | CACNA1E | Sponge network | 1.84 | 0 | 1.613 | 4.0E-5 | 0.31 |
53 | TOB1-AS1 | hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-150-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-218-5p;hsa-miR-2355-3p;hsa-miR-330-3p;hsa-miR-450b-5p | 10 | PRKCA | Sponge network | 0.811 | 0 | 0.663 | 0 | 0.308 |
54 | RP11-480I12.7 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-146b-3p;hsa-miR-150-5p;hsa-miR-214-5p;hsa-miR-2355-3p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-874-3p | 10 | MAPT | Sponge network | 2.03 | 0 | 2.585 | 0 | 0.308 |
55 | RP11-620J15.3 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p | 11 | CACNB4 | Sponge network | 2.159 | 0 | 1.931 | 0 | 0.308 |
56 | LINC01057 | hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-378a-5p;hsa-miR-497-5p;hsa-miR-548b-3p | 13 | CACNA1E | Sponge network | 1.427 | 3.0E-5 | 1.613 | 4.0E-5 | 0.307 |
57 | LINC01004 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p | 10 | CACNB4 | Sponge network | 2.116 | 0 | 1.931 | 0 | 0.304 |
58 | TPRG1-AS1 | hsa-miR-106b-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-338-3p;hsa-miR-93-5p | 10 | MAP3K2 | Sponge network | -0.756 | 0.03021 | -0.771 | 0 | 0.304 |
59 | RP13-582O9.5 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p | 10 | CACNB4 | Sponge network | 2.071 | 0 | 1.931 | 0 | 0.3 |
60 | ZFAS1 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-7-1-3p | 18 | CACNA1E | Sponge network | 1.155 | 0 | 1.613 | 4.0E-5 | 0.3 |
61 | GAS5 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-7-1-3p | 17 | CACNA1E | Sponge network | 1.966 | 0 | 1.613 | 4.0E-5 | 0.298 |
62 | RP11-479G22.8 | hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-424-5p;hsa-miR-497-5p | 12 | CACNA1E | Sponge network | 1.511 | 0 | 1.613 | 4.0E-5 | 0.298 |
63 | LINC01011 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 1.861 | 0 | 1.931 | 0 | 0.298 |
64 | FLVCR1-AS1 |
hsa-miR-10a-5p;hsa-miR-125b-2-3p;hsa-miR-214-5p;hsa-miR-27b-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-505-5p;hsa-miR-874-3p | 10 | MAPT | Sponge network | 2.147 | 0 | 2.585 | 0 | 0.297 |
65 | KB-1460A1.5 | hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-7-1-3p | 17 | CACNA1E | Sponge network | 1.949 | 0 | 1.613 | 4.0E-5 | 0.297 |
66 | CTD-3138B18.5 | hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p | 13 | CACNA1E | Sponge network | 1.228 | 0 | 1.613 | 4.0E-5 | 0.296 |
67 | AC004862.6 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-877-5p;hsa-miR-93-5p | 12 | MAP3K13 | Sponge network | -2.202 | 0.00081 | -0.449 | 0.05753 | 0.293 |
68 | LINC00238 |
hsa-miR-106b-5p;hsa-miR-1301-3p;hsa-miR-149-5p;hsa-miR-17-5p;hsa-miR-181a-5p;hsa-miR-181b-5p;hsa-miR-181c-5p;hsa-miR-188-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-502-5p | 11 | MAP3K13 | Sponge network | -4.997 | 0 | -0.449 | 0.05753 | 0.29 |
69 | RP11-798G7.6 | hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 1.23 | 0 | 1.931 | 0 | 0.288 |
70 | KB-1572G7.3 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-3614-5p;hsa-miR-424-5p;hsa-miR-497-5p | 15 | CACNA1E | Sponge network | 2.031 | 0 | 1.613 | 4.0E-5 | 0.287 |
71 | PVT1 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-424-5p;hsa-miR-497-5p | 16 | CACNA1E | Sponge network | 2.645 | 0 | 1.613 | 4.0E-5 | 0.286 |
72 | SNHG12 |
hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 17 | CACNA1E | Sponge network | 1.791 | 0 | 1.613 | 4.0E-5 | 0.285 |
73 | RP11-1246C19.1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p | 11 | CACNB4 | Sponge network | 2.721 | 0 | 1.931 | 0 | 0.284 |
74 | RP11-1149M10.2 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-30e-3p | 13 | CACNA1E | Sponge network | 1.302 | 0.02179 | 1.613 | 4.0E-5 | 0.284 |
75 | SNHG12 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 1.791 | 0 | 1.931 | 0 | 0.282 |
76 | RP1-228H13.5 | hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p | 14 | CACNA1E | Sponge network | 1.554 | 0 | 1.613 | 4.0E-5 | 0.282 |
77 | XX-C2158C6.3 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-195-5p;hsa-miR-30a-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 10 | CACNA1E | Sponge network | 6.121 | 0 | 1.613 | 4.0E-5 | 0.282 |
78 | RP11-20I23.13 | hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3614-5p;hsa-miR-424-5p | 10 | CACNA1E | Sponge network | 1.015 | 0 | 1.613 | 4.0E-5 | 0.28 |
79 | CTC-444N24.11 | hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-424-5p;hsa-miR-497-5p | 13 | CACNA1E | Sponge network | 1.087 | 0 | 1.613 | 4.0E-5 | 0.279 |
80 | LINC00638 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 12 | CACNB4 | Sponge network | 1.756 | 0 | 1.931 | 0 | 0.275 |
81 | CTBP1-AS2 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 1.419 | 0 | 1.931 | 0 | 0.273 |
82 | TEX41 | hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 14 | CACNA1E | Sponge network | 3.293 | 0 | 1.613 | 4.0E-5 | 0.273 |
83 | RP11-110G21.1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 1.338 | 0 | 1.931 | 0 | 0.273 |
84 | LINC00511 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-497-5p | 17 | CACNA1E | Sponge network | 2.468 | 0 | 1.613 | 4.0E-5 | 0.273 |
85 | AC006547.13 | hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30e-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 13 | CACNA1E | Sponge network | 1.39 | 0 | 1.613 | 4.0E-5 | 0.273 |
86 | AC073283.4 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p;hsa-miR-542-3p | 12 | CACNB4 | Sponge network | 1.514 | 0 | 1.931 | 0 | 0.271 |
87 | RP11-166D19.1 |
hsa-miR-130b-3p;hsa-miR-151a-5p;hsa-miR-17-3p;hsa-miR-185-5p;hsa-miR-186-5p;hsa-miR-361-5p;hsa-miR-421;hsa-miR-532-5p;hsa-miR-590-5p;hsa-miR-618 | 10 | NTRK2 | Sponge network | -0.244 | 0.28835 | -2.305 | 0 | 0.271 |
88 | RP11-73M18.8 | hsa-let-7a-5p;hsa-let-7b-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-424-5p | 10 | CACNA1E | Sponge network | 1.234 | 0 | 1.613 | 4.0E-5 | 0.27 |
89 | AP001469.9 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 2.428 | 0 | 1.931 | 0 | 0.269 |
90 | RP11-115D19.1 | hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30e-3p | 10 | CACNA1E | Sponge network | 2.584 | 0.00064 | 1.613 | 4.0E-5 | 0.269 |
91 | HOXA11-AS |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p | 10 | CACNB4 | Sponge network | 6.056 | 0 | 1.931 | 0 | 0.269 |
92 | GUSBP11 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 17 | CACNA1E | Sponge network | 2.066 | 0 | 1.613 | 4.0E-5 | 0.266 |
93 | AC005154.6 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 1.75 | 0 | 1.931 | 0 | 0.265 |
94 | TMCC1-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 12 | CACNB4 | Sponge network | 2.298 | 0 | 1.931 | 0 | 0.264 |
95 | MAPKAPK5-AS1 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-505-3p | 17 | CACNA1E | Sponge network | 1.411 | 0 | 1.613 | 4.0E-5 | 0.26 |
96 | SSTR5-AS1 | hsa-let-7a-2-3p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-505-3p | 10 | CACNA1E | Sponge network | 3.192 | 0.00084 | 1.613 | 4.0E-5 | 0.26 |
97 | LINC00528 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-30a-3p;hsa-miR-378a-5p | 14 | CACNA1E | Sponge network | 1.854 | 0 | 1.613 | 4.0E-5 | 0.259 |
98 | RP4-758J18.13 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7f-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p | 12 | CACNA1E | Sponge network | 1.374 | 0 | 1.613 | 4.0E-5 | 0.258 |
99 | PXN-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p | 11 | CACNB4 | Sponge network | 1.561 | 0 | 1.931 | 0 | 0.257 |
100 | RP11-328N19.1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-505-3p | 10 | CACNB4 | Sponge network | 7.657 | 0 | 1.931 | 0 | 0.256 |
101 | RP5-1074L1.4 |
hsa-let-7a-2-3p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 14 | CACNA1E | Sponge network | 2.302 | 0 | 1.613 | 4.0E-5 | 0.256 |
102 | SNHG17 |
hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-505-3p | 19 | CACNA1E | Sponge network | 1.214 | 0 | 1.613 | 4.0E-5 | 0.254 |
103 | SNHG1 | hsa-let-7a-2-3p;hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-3p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 18 | CACNA1E | Sponge network | 2.013 | 0 | 1.613 | 4.0E-5 | 0.254 |
104 | RP11-800A18.4 | hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 11 | CACNA1E | Sponge network | 5.766 | 0 | 1.613 | 4.0E-5 | 0.254 |
105 | PVT1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30e-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 11 | CACNB4 | Sponge network | 2.645 | 0 | 1.931 | 0 | 0.253 |
106 | AC062029.1 | hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-142-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-199a-5p;hsa-miR-26a-5p;hsa-miR-424-5p;hsa-miR-497-5p | 10 | CACNB4 | Sponge network | 1.067 | 0 | 1.931 | 0 | 0.253 |
107 | BAIAP2-AS1 |
hsa-let-7b-5p;hsa-let-7g-3p;hsa-miR-139-5p;hsa-miR-144-3p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-424-5p;hsa-miR-497-5p;hsa-miR-542-3p | 10 | CACNB4 | Sponge network | 1.249 | 0 | 1.931 | 0 | 0.251 |
108 | STXBP5-AS1 | hsa-let-7a-2-3p;hsa-let-7g-3p;hsa-let-7g-5p;hsa-miR-101-5p;hsa-miR-125b-2-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-28-5p;hsa-miR-30a-3p;hsa-miR-30e-3p;hsa-miR-3614-5p;hsa-miR-378a-5p;hsa-miR-424-5p;hsa-miR-548b-3p | 15 | CACNA1E | Sponge network | 1.715 | 0 | 1.613 | 4.0E-5 | 0.251 |